Arturo Casadevall
#28,238
Most Influential Person Now
Cuban-American scientist
Arturo Casadevall's AcademicInfluence.com Rankings
Arturo Casadevallbiology Degrees
Biology
#836
World Rank
#1451
Historical Rank
#450
USA Rank
Virology
#20
World Rank
#21
Historical Rank
#9
USA Rank
Microbiology
#19
World Rank
#30
Historical Rank
#14
USA Rank
Immunology
#36
World Rank
#40
Historical Rank
#13
USA Rank
Download Badge
Biology
Arturo Casadevall's Degrees
- Bachelors Microbiology University of Miami
- Masters Microbiology University of Miami
- PhD Microbiology New York University
- Masters Medicine New York University
Why Is Arturo Casadevall Influential?
(Suggest an Edit or Addition)According to Wikipedia, Arturo Casadevall is a Bloomberg Distinguished Professor of Molecular Microbiology & Immunology and Infectious Diseases at the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins School of Medicine, and the Alfred and Jill Sommer Professor and Chair of the W. Harry Feinstone Department of Molecular Microbiology and Immunology at the Johns Hopkins Bloomberg School of Public Health. He is an internationally recognized expert in infectious disease research, with a focus on fungal and bacterial pathogenesis and basic immunology of antibody structure-function. He was elected a member of the National Academy of Sciences in 2022.
Arturo Casadevall's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Misconduct accounts for the majority of retracted scientific publications (2012) (927)
- The convalescent sera option for containing COVID-19. (2020) (826)
- Through the wall: extracellular vesicles in Gram-positive bacteria, mycobacteria and fungi (2015) (774)
- Deployment of convalescent plasma for the prevention and treatment of COVID-19. (2020) (684)
- Host-Pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity (1999) (664)
- The contribution of melanin to microbial pathogenesis (2003) (559)
- The damage-response framework of microbial pathogenesis (2003) (519)
- Synthesis and assembly of fungal melanin (2012) (507)
- Host-Pathogen Interactions: Basic Concepts of Microbial Commensalism, Colonization, Infection, and Disease (2000) (491)
- Urease as a Virulence Factor in Experimental Cryptococcosis (2000) (477)
- Passive antibody therapy for infectious diseases (2004) (475)
- Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages (2001) (463)
- Extracellular Vesicles Produced by Cryptococcus neoformans Contain Protein Components Associated with Virulence (2007) (442)
- Cryptococcus neoformans var.grubii: Separate Varietal Status for Cryptococcus neoformans Serotype A Isolates (1999) (425)
- Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection (2000) (422)
- Early safety indicators of COVID-19 convalescent plasma in 5,000 patients. (2020) (421)
- Host-pathogen interactions: the attributes of virulence. (2001) (400)
- Ionizing Radiation Changes the Electronic Properties of Melanin and Enhances the Growth of Melanized Fungi (2007) (395)
- Vesicular Polysaccharide Export in Cryptococcus neoformans Is a Eukaryotic Solution to the Problem of Fungal Trans-Cell Wall Transport (2006) (388)
- Serologic evidence for Cryptococcus neoformans infection in early childhood. (2001) (388)
- The capsule of the fungal pathogen Cryptococcus neoformans. (2009) (387)
- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19 (2021) (376)
- Cryptococcus neoformans melanin and virulence: mechanism of action (1995) (374)
- Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study (2020) (364)
- An insight into the antifungal pipeline: selected new molecules and beyond (2010) (363)
- Phagosome Extrusion and Host-Cell Survival after Cryptococcus neoformans Phagocytosis by Macrophages (2006) (363)
- Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans (2001) (356)
- Impact of Melanin on Microbial Virulence and Clinical Resistance to Antimicrobial Compounds (2006) (337)
- Why Has the Number of Scientific Retractions Increased? (2013) (328)
- Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three-Month Experience (2020) (324)
- Quorum sensing in fungi--a review. (2012) (318)
- Return to the Past: The Case for Antibody-Based Therapies in Infectious Diseases (1995) (309)
- Ionizing radiation: how fungi cope, adapt, and exploit with the help of melanin. (2008) (297)
- Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm (2002) (294)
- Characterization of a Murine Monoclonal Antibody toCryptococcus neoformans Polysaccharide That Is a Candidate for Human Therapeutic Studies (1998) (294)
- Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans‐cell wall transfer of proteins and lipids in ascomycetes (2008) (293)
- Melanin and virulence in Cryptococcus neoformans. (2000) (293)
- Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins (2010) (291)
- Retracted Science and the Retraction Index (2011) (290)
- The Case for Adopting the “Species Complex” Nomenclature for the Etiologic Agents of Cryptococcosis (2017) (288)
- Protective murine monoclonal antibodies to Cryptococcus neoformans (1992) (287)
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population (2020) (282)
- Fungal Cell Gigantism during Mammalian Infection (2010) (280)
- Antibody immunity and invasive fungal infections (1995) (277)
- A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival. (1998) (272)
- Mycobacteria release active membrane vesicles that modulate immune responses in a TLR2-dependent manner in mice. (2011) (270)
- Superoxide Dismutase Influences the Virulence of Cryptococcus neoformans by Affecting Growth within Macrophages (2003) (257)
- Serum therapy revisited: animal models of infection and development of passive antibody therapy (1994) (245)
- Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants (1994) (241)
- Global Warming Will Bring New Fungal Diseases for Mammals (2010) (231)
- Melanization of Cryptococcus neoformans and Histoplasma capsulatum Reduces Their Susceptibilities to Amphotericin B and Caspofungin (2002) (225)
- Reactive nitrogen intermediates in human neuropathology: an overview. (1994) (222)
- Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival (2008) (220)
- Safety Update (2020) (215)
- The spectrum of fungi that infects humans. (2014) (215)
- Serum Therapy for Tuberculosis Revisited: Reappraisal of the Role of Antibody-Mediated Immunity againstMycobacterium tuberculosis (1998) (213)
- Intracellular parasitism of macrophages by Cryptococcus neoformans. (2001) (212)
- Functions of fungal melanin beyond virulence. (2017) (209)
- 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm. (2003) (208)
- Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. (2001) (207)
- Decreased susceptibility of melanized Cryptococcus neoformans to UV light (1994) (201)
- Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis (2005) (199)
- Extracellular Vesicles from Cryptococcus neoformans Modulate Macrophage Functions (2010) (199)
- Experimental modulation of capsule size in Cryptococcus neoformans (2004) (197)
- Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. (1996) (195)
- Characterization of Yeast Extracellular Vesicles: Evidence for the Participation of Different Pathways of Cellular Traffic in Vesicle Biogenesis (2010) (194)
- Laccase of Cryptococcus neoformans Is a Cell Wall-Associated Virulence Factor (2001) (192)
- Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell (1995) (191)
- Antibodies elicited by a Cryptococcus neoformans-tetanus toxoid conjugate vaccine have the same specificity as those elicited in infection. (1992) (190)
- Fungal Melanin: What do We Know About Structure? (2015) (184)
- Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans (2015) (183)
- CR3 (CD11b/CD18) and CR4 (CD11c/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans. (2002) (176)
- Microevolution of a Standard Strain ofCryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes (1998) (175)
- Exploiting Amoeboid and Non-Vertebrate Animal Model Systems to Study the Virulence of Human Pathogenic Fungi (2007) (174)
- Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons (2002) (174)
- Susceptibility of Cryptococcus neoformans Biofilms to Antifungal Agents In Vitro (2006) (169)
- T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice. (1997) (169)
- Vertebrate endothermy restricts most fungi as potential pathogens. (2009) (168)
- Causes for the Persistence of Impact Factor Mania (2014) (167)
- Antibody-mediated regulation of cellular immunity and the inflammatory response. (2003) (167)
- Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages (1995) (166)
- The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. (2003) (166)
- Characterization of protective extracellular membrane-derived vesicles produced by Streptococcus pneumoniae. (2014) (166)
- Threats Posed by the Fungal Kingdom to Humans, Wildlife, and Agriculture (2020) (163)
- Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat (1994) (162)
- The role of B cells and humoral immunity in Mycobacterium tuberculosis infection. (2014) (162)
- Induction of Capsule Growth in Cryptococcus neoformans by Mammalian Serum and CO2 (2003) (161)
- Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum. (2003) (159)
- Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans (1996) (157)
- Antibody-mediated immunity against tuberculosis: implications for vaccine development. (2013) (157)
- Cryptococcus neoformans Biofilm Formation Depends on Surface Support and Carbon Source and Reduces Fungal Cell Susceptibility to Heat, Cold, and UV Light (2007) (157)
- More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG1 (2003) (156)
- Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding (1997) (155)
- A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. (2006) (154)
- B cells and antibodies in the defense against Mycobacterium tuberculosis infection (2015) (151)
- Use of Licensed Vaccines for Active Immunization of the Immunocompromised Host (1998) (151)
- Monoclonal antibody based ELISAs for cryptococcal polysaccharide. (1992) (151)
- Monoclonal antibody-based therapies for microbial diseases (2009) (150)
- Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. (1997) (150)
- Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization (1993) (148)
- SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals. (2021) (147)
- Isotype switching from IgG3 to IgG1 converts a nonprotective murine antibody to Cryptococcus neoformans into a protective antibody. (1995) (147)
- Evidence of Zoonotic Transmission of Cryptococcus neoformans from a Pet Cockatoo to an Immunocompromised Patient (2000) (146)
- Synthesis of Polymerized Melanin by Cryptococcus neoformans in Infected Rodents (2000) (145)
- Cryptococcus neoformans Virulence Is Enhanced after Growth in the Genetically Malleable Host Dictyostelium discoideum (2003) (144)
- Sec6‐dependent sorting of fungal extracellular exosomes and laccase of Cryptococcus neoformans (2009) (143)
- Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. (1997) (143)
- The Prevalence of Inappropriate Image Duplication in Biomedical Research Publications (2016) (143)
- Accidental Virulence, Cryptic Pathogenesis, Martians, Lost Hosts, and the Pathogenicity of Environmental Microbes (2007) (142)
- Persistence of initial infection in recurrent Cryptococcus neoformans meningitis (1993) (141)
- Persistent Cryptococcus neoformansPulmonary Infection in the Rat Is Associated with Intracellular Parasitism, Decreased Inducible Nitric Oxide Synthase Expression, and Altered Antibody Responsiveness to Cryptococcal Polysaccharide (2000) (141)
- Roles for inositol-phosphoryl ceramide synthase 1 (IPC1) in pathogenesis of C. neoformans. (2001) (141)
- Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective Efficacy (2005) (140)
- Hark back: Passive immunotherapy for influenza and other serious infections (2010) (139)
- On Virulence (2010) (138)
- Role for Mycobacterium tuberculosis Membrane Vesicles in Iron Acquisition (2014) (134)
- Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. (2012) (134)
- A new synthesis for antibody-mediated immunity (2011) (133)
- Fcγ Receptors Regulate Immune Activation and Susceptibility during Mycobacterium tuberculosis Infection1 (2008) (133)
- The Physical Properties of the Capsular Polysaccharides from Cryptococcus neoformans Suggest Features for Capsule Construction* (2006) (132)
- The immunoglobulin constant region contributes to affinity and specificity. (2008) (132)
- Vesicular transport across the fungal cell wall. (2009) (131)
- The Presence of Female Conveners Correlates with a Higher Proportion of Female Speakers at Scientific Symposia (2014) (130)
- Melanin as a potential cryptococcal defence against microbicidal proteins. (1999) (129)
- Self-Aggregation of Cryptococcus neoformans Capsular Glucuronoxylomannan Is Dependent on Divalent Cations (2007) (129)
- Antibody-mediated protection against intracellular pathogens. (1998) (128)
- Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. (2020) (127)
- Cryptococcus neoformans laccase catalyses melanin synthesis from both D- and L-DOPA. (2007) (127)
- Passive Immunization with Melanin-Binding Monoclonal Antibodies Prolongs Survival of Mice with Lethal Cryptococcus neoformans Infection (2001) (127)
- Neutropenia alters lung cytokine production in mice and reduces their susceptibility to pulmonary cryptococcosis (2003) (127)
- Detection of Melanin-Like Pigments in the Dimorphic Fungal Pathogen Paracoccidioides brasiliensis In Vitro and during Infection (2001) (126)
- The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. (2000) (126)
- Cryptococcus neoformans α Strains Preferentially Disseminate to the Central Nervous System during Coinfection (2005) (125)
- Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B (1994) (125)
- Organ-Dependent Variation of Capsule Thickness inCryptococcus neoformans during Experimental Murine Infection (1998) (124)
- The radioprotective properties of fungal melanin are a function of its chemical composition, stable radical presence and spatial arrangement (2007) (122)
- Fungi that Infect Humans. (2017) (121)
- Evolution of intracellular pathogens. (2008) (121)
- Phenotypic Switching in Cryptococcus neoformansResults in Changes in Cellular Morphology and Glucuronoxylomannan Structure (1999) (121)
- Vesicle-associated melanization in Cryptococcus neoformans. (2009) (121)
- Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice (1994) (120)
- Financial costs and personal consequences of research misconduct resulting in retracted publications (2014) (120)
- Antibody-Mediated Immunity against Intracellular Pathogens: Two-Dimensional Thinking Comes Full Circle (2003) (120)
- Early Outpatient Treatment for Covid-19 with Convalescent Plasma (2022) (120)
- Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. (2005) (120)
- Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro (1997) (119)
- Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? (2005) (119)
- Serologic Evidence for Reactivation of Cryptococcosis in Solid-Organ Transplant Recipients (2007) (119)
- The Immunoglobulin Heavy Chain Constant Region Affects Kinetic and Thermodynamic Parameters of Antibody Variable Region Interactions with Antigen* (2007) (119)
- Melanisation of Cryptococcus neoformans in human brain tissue (2000) (119)
- Nonlytic Exocytosis of Cryptococcus neoformans from Macrophages Occurs In Vivo and Is Influenced by Phagosomal pH (2011) (119)
- Cell-to-cell spread and massive vacuole formation after Cryptococcus neoformans infection of murine macrophages (2007) (118)
- Reductionistic and Holistic Science (2011) (118)
- Reforming Science: Methodological and Cultural Reforms (2011) (117)
- Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. (1993) (117)
- Convalescent plasma treatment of severe COVID-19: A matched control study (2020) (117)
- The use of chitosan to damage Cryptococcus neoformans biofilms. (2010) (116)
- The efficacy of complement‐mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3‐mediated interactions (2003) (116)
- Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. (2001) (114)
- Histoplasma capsulatum Synthesizes Melanin-Like Pigments In Vitro and during Mammalian Infection (2002) (114)
- Cryptococcus neoformans CAP59 (or Cap59p) Is Involved in the Extracellular Trafficking of Capsular Glucuronoxylomannan (2004) (113)
- The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation (2003) (113)
- Human astrocytes inhibit Cryptococcus neoformans growth by a nitric oxide-mediated mechanism (1994) (112)
- Antibody-based therapies for emerging infectious diseases. (1996) (111)
- Epitope Location in the Cryptococcus neoformans Capsule Is a Determinant of Antibody Efficacy (1997) (111)
- Interaction of Blastomyces dermatitidis, Sporothrix schenckii, and Histoplasma capsulatum with Acanthamoeba castellanii (2004) (110)
- The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies (1991) (109)
- Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans (2001) (109)
- The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis (2021) (109)
- Virulence factors and their mechanisms of action: the view from a damage-response framework. (2009) (109)
- Extracellular vesicles produced by the Gram‐positive bacterium Bacillus subtilis are disrupted by the lipopeptide surfactin (2014) (108)
- Nontoxic radioactive Listeriaat is a highly effective therapy against metastatic pancreatic cancer (2013) (108)
- Reproducible Science (2010) (107)
- Phospholipids Trigger Cryptococcus neoformans Capsular Enlargement during Interactions with Amoebae and Macrophages (2011) (107)
- The Viscoelastic Properties of the Fungal Cell Wall Allow Traffic of AmBisome as Intact Liposome Vesicles (2018) (107)
- Cryptococcus: from human pathogen to model yeast. (2010) (107)
- Enhancement of HIV-1 infection by the capsular polysaccharide of Cryptococcus neoformans (1992) (107)
- Extracellular proteinase activity of Cryptococcus neoformans (1996) (106)
- Macrophage Autophagy in Immunity to Cryptococcus neoformans and Candida albicans (2012) (106)
- Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. (1998) (106)
- The intracellular life of Cryptococcus neoformans. (2014) (105)
- Microbiology: Ditch the term pathogen (2014) (105)
- On the Emergence of Candida auris: Climate Change, Azoles, Swamps, and Birds (2019) (105)
- Immunoglobulin M Efficacy Against Cryptococcus neoformans: Mechanism, Dose Dependence, and Prozone-Like Effects in Passive Protection Experiments1 (2001) (104)
- A requirement for FcγR in antibody-mediated bacterial toxin neutralization (2010) (103)
- Melanin-covered nanoparticles for protection of bone marrow during radiation therapy of cancer. (2010) (103)
- Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers (2020) (103)
- Ionizing radiation delivered by specific antibody is therapeutic against a fungal infection (2003) (102)
- Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility. (2006) (99)
- Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis (1995) (99)
- Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from India (2005) (99)
- On the emergence of Candida auris: climate change, azoles, swamps and birds (2019) (98)
- Cryptococcus neoformans Capsular Enlargement and Cellular Gigantism during Galleria mellonella Infection (2011) (98)
- Research Funding: the Case for a Modified Lottery (2016) (98)
- Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B (1994) (97)
- Ecology of Cryptococcus neoformans (1998) (97)
- The antibody response to fungal melanin in mice. (1998) (96)
- Capsule of Cryptococcus neoformans grows by enlargement of polysaccharide molecules (2009) (96)
- Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody (1995) (96)
- Titan cells formation in Cryptococcus neoformans is finely tuned by environmental conditions and modulated by positive and negative genetic regulators (2017) (96)
- Synthesis of Melanin-Like Pigments by Sporothrix schenckii In Vitro and during Mammalian Infection (2003) (96)
- Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole (1993) (96)
- Q and A What is a pathogen? A question that begs the point (2012) (95)
- Cryptococcus neoformans Capsular Polysaccharide and Exopolysaccharide Fractions Manifest Physical, Chemical, and Antigenic Differences (2007) (95)
- Association of Human Antibodies to Arabinomannan With Enhanced Mycobacterial Opsonophagocytosis and Intracellular Growth Reduction (2016) (94)
- The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response (2007) (93)
- The capsule of Cryptococcus neoformans (2018) (92)
- Cryptococcus neoformans Capsular Glucuronoxylomannan Induces Expression of Fas Ligand in Macrophages1 (2005) (92)
- The polysaccharide capsule of the pathogenic fungus Cryptococcus neoformans enlarges by distal growth and is rearranged during budding (2006) (92)
- Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen1 (2002) (92)
- Ab binding alters gene expression in Cryptococcus neoformans and directly modulates fungal metabolism. (2010) (92)
- Binding of the Wheat Germ Lectin to Cryptococcus neoformans Suggests an Association of Chitinlike Structures with Yeast Budding and Capsular Glucuronoxylomannan (2007) (92)
- Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. (2001) (91)
- SARS-CoV-2 Antibody Avidity Responses in COVID-19 Patients and Convalescent Plasma Donors (2020) (91)
- Adaptations of Avian Flu Virus Are a Cause for Concern (2012) (91)
- The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. (1997) (89)
- Melanization of Cryptococcus neoformans Affects Lung Inflammatory Responses during Cryptococcal Infection (2005) (89)
- Aging-related anatomical and biochemical changes in lymphatic collectors impair lymph transport, fluid homeostasis, and pathogen clearance (2015) (89)
- Fungal morphogenesis and virulence. (2000) (89)
- Passive antibody therapies: progress and continuing challenges. (1999) (89)
- A Randomized Trial of Convalescent Plasma for COVID-19-Potentially Hopeful Signals. (2020) (89)
- Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans (2007) (87)
- Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City. (2000) (87)
- Recent progress in vaccines against fungal diseases. (2012) (87)
- What Is a Host? Incorporating the Microbiota into the Damage-Response Framework (2014) (87)
- Isotype Switching Increases Efficacy of Antibody Protection against Cryptococcus neoformans Infection in Mice (1998) (87)
- Identification and characterization of the Cryptococcus neoformans phosphomannose isomerase‐encoding gene, MAN1, and its impact on pathogenicity (2001) (87)
- Immunoglobulin G Monoclonal Antibodies to Cryptococcus neoformans Protect Mice Deficient in Complement Component C3 (2002) (87)
- Cryptococcus neoformans var. neoformans(Serotype D) Strains Are More Susceptible to Heat than C. neoformans var. grubii (Serotype A) Strains (2001) (86)
- Induced humoral immunity and vaccination against major human fungal pathogens. (2002) (85)
- The capsular dynamics of Cryptococcus neoformans. (2006) (85)
- Vesicular Trans-Cell Wall Transport in Fungi: A Mechanism for the Delivery of Virulence-Associated Macromolecules? (2008) (85)
- Antibody Efficacy in Murine Pulmonary Cryptococcus neoformans Infection: A Role for Nitric Oxide1 (2002) (85)
- Molecular Characterization of a cDNA That Encodes Six Isoforms of a Novel Murine A Kinase Anchor Protein* (1998) (83)
- Quorum Sensing-Mediated, Cell Density-Dependent Regulation of Growth and Virulence in Cryptococcus neoformans (2013) (83)
- Ig Constant Region Effects on Variable Region Structure and Function (2016) (83)
- Immunohistochemical localization of capsular polysaccharide antigen in the central nervous system cells in cryptococcal meningoencephalitis. (1996) (83)
- NIH peer review percentile scores are poorly predictive of grant productivity (2016) (82)
- Virulence-Associated Enzymes of Cryptococcus neoformans (2015) (82)
- Glucuronoxylomannan, a microbial compound, regulates expression of costimulatory molecules and production of cytokines in macrophages. (2005) (82)
- Fc gamma receptors regulate immune activation and susceptibility during Mycobacterium tuberculosis infection. (2008) (82)
- Variable-Region-Identical Antibodies Differing in Isotype Demonstrate Differences in Fine Specificity and Idiotype1 (2005) (82)
- Evidence favouring the efficacy of convalescent plasma for COVID-19 therapy (2020) (82)
- Following fungal melanin biosynthesis with solid-state NMR: biopolymer molecular structures and possible connections to cell-wall polysaccharides. (2008) (81)
- The Damage-Response Framework of Microbial Pathogenesis and Infectious Diseases (2008) (81)
- Cryptococcus neoformans survive and replicate in human microglia. (1995) (81)
- Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate. (2001) (81)
- Release of mycobacterial antigens (2015) (80)
- Serum cryptococcal antigen in patients with AIDS. (1996) (80)
- Isolation and serological analyses of fungal melanins. (2000) (80)
- Cryptococcus neoformans Cells in Biofilms Are Less Susceptible than Planktonic Cells to Antimicrobial Molecules Produced by the Innate Immune System (2006) (80)
- Synthesis of Melanin Pigment by Candida albicans In Vitro and during Infection (2005) (80)
- Microbial Virulence as an Emergent Property: Consequences and Opportunities (2011) (79)
- Effects of disrupting the polyketide synthase gene WdPKS1 in Wangiella [Exophiala] dermatitidis on melanin production and resistance to killing by antifungal compounds, enzymatic degradation, and extremes in temperature (2006) (79)
- Cryptococci at the brain gate: break and enter or use a Trojan horse? (2010) (79)
- Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. (1998) (79)
- Estimating the Relative Contributions of Virulence Factors for Pathogenic Microbes (2006) (79)
- Determinants of virulence in the pathogenic fungi. (2007) (79)
- Faculty Opinions recommendation of B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis. (2007) (78)
- Mycobacterial Membrane Vesicles Administered Systemically in Mice Induce a Protective Immune Response to Surface Compartments of Mycobacterium tuberculosis (2014) (78)
- Targeted Killing of Virally Infected Cells by Radiolabeled Antibodies to Viral Proteins (2006) (78)
- Effects of Voriconazole on Cryptococcus neoformans (2004) (78)
- Cryptococcus neoformans Can Utilize the Bacterial Melanin Precursor Homogentisic Acid for Fungal Melanogenesis (2006) (78)
- Competitive Science: Is Competition Ruining Science? (2015) (78)
- Melanization of Cryptococcus neoformansin Murine Infection (1999) (78)
- Crisis in infectious diseases: time for a new paradigm? (1996) (77)
- New Concepts in Antibody-Mediated Immunity (2004) (77)
- Antibody-Mediated Protection in Murine Cryptococcus neoformans Infection Is Associated with Pleotrophic Effects on Cytokine and Leukocyte Responses (2002) (77)
- Genetic regulation of vesiculogenesis and immunomodulation in Mycobacterium tuberculosis (2013) (76)
- Lost in Translation—Basic Science in the Era of Translational Research (2009) (76)
- Radiological Studies Reveal Radial Differences in the Architecture of the Polysaccharide Capsule of Cryptococcus neoformans (2005) (76)
- The Pathogenic Potential of a Microbe (2017) (76)
- Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan (1994) (75)
- Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research (2015) (75)
- Adjunctive immune therapy for fungal infections. (2001) (74)
- Lipophilic Dye Staining of Cryptococcus neoformans Extracellular Vesicles and Capsule (2009) (74)
- Antibody Response to Cryptococcus neoformans Proteins in Rodents and Humans (1999) (74)
- Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans (1994) (74)
- Antibody-Mediated Protection against Cryptococcus neoformans Pulmonary Infection Is Dependent on B Cells (2005) (73)
- Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence (2011) (73)
- Monoclonal antibodies to surface antigens of Mycobacterium tuberculosis and their use in a modified enzyme-linked immunosorbent spot assay for detection of mycobacteria (1996) (73)
- The Transcriptional Response of Cryptococcus neoformans to Ingestion by Acanthamoeba castellanii and Macrophages Provides Insights into the Evolutionary Adaptation to the Mammalian Host (2013) (73)
- Listeria monocytogenes virulence factors, including listeriolysin O, are secreted in biologically active extracellular vesicles (2018) (73)
- Interaction of Cryptococcus neoformans Extracellular Vesicles with the Cell Wall (2014) (72)
- Males Are Overrepresented among Life Science Researchers Committing Scientific Misconduct (2013) (71)
- Mammalian Endothermy Optimally Restricts Fungi and Metabolic Costs (2010) (71)
- Physico-Chemical Evaluation of Rationally Designed Melanins as Novel Nature-Inspired Radioprotectors (2009) (71)
- Evidence That Cryptococcus neoformans Is Melanized in Pigeon Excreta: Implications for Pathogenesis (1999) (71)
- Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? (1998) (71)
- Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. (1996) (70)
- Fungi and the Rise of Mammals (2012) (70)
- Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T‐cells through activation of caspase‐8 (2006) (70)
- Correction: Fungal Cell Gigantism during Mammalian Infection (2010) (69)
- Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. (2005) (69)
- Sources of error in the retracted scientific literature (2014) (69)
- Phagocytosis of Cryptococcus neoformans by, and Nonlytic Exocytosis from, Acanthamoeba castellanii (2010) (69)
- Cryptococcus neoformans urease affects the outcome of intracellular pathogenesis by modulating phagolysosomal pH (2018) (69)
- Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation (2004) (68)
- Extensive allelic variation in Cryptococcus neoformans (1992) (68)
- An Innate Immune System Cell Is a Major Determinant of Species-Related Susceptibility Differences to Fungal Pneumonia1 (2005) (67)
- Cryptococcal therapies and drug targets: the old, the new and the promising (2016) (66)
- Enhanced allergic inflammation and airway responsiveness in rats with chronic Cryptococcus neoformans infection: potential role for fungal pulmonary infection in the pathogenesis of asthma. (2006) (66)
- Immunomodulatory Effects of Serotype B Glucuronoxylomannan from Cryptococcus gattii Correlate with Polysaccharide Diameter (2010) (66)
- Biofilm Formation by Cryptococcus neoformans. (2015) (65)
- Intracellular pathogenic bacteria and fungi — a case of convergent evolution? (2009) (65)
- Biological Correlates of Capsular (Quellung) Reactions of Cryptococcus neoformans1 (2000) (65)
- Current Topics in Microbiology and Immunology (1985) (65)
- Immunoglobulin G3 blocking antibodies to the fungal pathogen Cryptococcus neoformans (1996) (64)
- Capsule and melanin synthesis in Cryptococcus neoformans. (2001) (64)
- Dead cells in melanoma tumors provide abundant antigen for targeted delivery of ionizing radiation by a mAb to melanin. (2004) (64)
- Immune complexes increase nitric oxide production by interferon‐γ‐stimulated murine macrophage‐like J774.16 cells (1995) (64)
- The Role of Host Gender in the Pathogenesis of Cryptococcus neoformans Infections (2013) (63)
- Enhanced control of Mycobacterium tuberculosis extrapulmonary dissemination in mice by an arabinomannan-protein conjugate vaccine (2017) (63)
- Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro (1997) (63)
- Amphotericin B and Fluconazole Affect Cellular Charge, Macrophage Phagocytosis, and Cellular Morphology of Cryptococcus neoformans at Subinhibitory Concentrations (1999) (63)
- Antibody-mediated effects against Cryptococcus neoformans: evidence for interdependency and collaboration between humoral and cellular immunity. (1998) (63)
- Characterization of Alternaria infectoria extracellular vesicles. (2014) (62)
- Amoeba provide insight into the origin of virulence in pathogenic fungi. (2012) (62)
- The tools for virulence of Cryptococcus neoformans. (2014) (62)
- Vesicular transport systems in fungi. (2011) (61)
- Antigen-Induced Protective and Nonprotective Cell-Mediated Immune Components against Cryptococcus neoformans (1998) (61)
- Use of convalescent plasma in COVID‐19 patients with immunosuppression (2021) (61)
- Activation of the Alternative Complement Pathway by Fungal Melanins (2002) (61)
- Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity (2011) (61)
- New insights on the pathogenesis of invasive Cryptococcus neoformans infection (2007) (61)
- J774 murine macrophage-like cell interactions with Cryptococcus neoformans in the presence and absence of opsonins. (1996) (60)
- Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response (2017) (60)
- Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in vitro (2016) (60)
- Risks and Benefits of Gain-of-Function Experiments with Pathogens of Pandemic Potential, Such as Influenza Virus: a Call for a Science-Based Discussion (2014) (60)
- Capsules from Pathogenic and Non-Pathogenic Cryptococcus spp. Manifest Significant Differences in Structure and Ability to Protect against Phagocytic Cells (2012) (60)
- Human and murine immunoglobulin expression vector cassettes. (2000) (60)
- Isothermal Titration Calorimetry Reveals Differential Binding Thermodynamics of Variable Region-identical Antibodies Differing in Constant Region for a Univalent Ligand* (2008) (60)
- The meaning of microbial exposure, infection, colonisation, and disease in clinical practice. (2002) (59)
- Induction by Klebsiella aerogenes of a Melanin-Like Pigment in Cryptococcus neoformans (2006) (59)
- Impacted Science: Impact Is Not Importance (2015) (59)
- Achieving Speaker Gender Equity at the American Society for Microbiology General Meeting (2015) (58)
- Development of vaccines and their use in the prevention of fungal infections. (1998) (58)
- Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan. (2009) (58)
- Ten Challenges on Cryptococcus and Cryptococcosis (2012) (58)
- The structural unit of melanin in the cell wall of the fungal pathogen Cryptococcus neoformans (2019) (58)
- Role for Chitin and Chitooligomers in the Capsular Architecture of Cryptococcus neoformans (2009) (58)
- Effect of immune mechanisms on the pharmacokinetics and organ distribution of cryptococcal polysaccharide. (1998) (57)
- Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. (2005) (57)
- Sterol composition of Cryptococcus neoformans in the presence and absence of fluconazole (1994) (57)
- Glucan Is a Component of the Mycobacterium tuberculosis Surface That Is Expressed In Vitro and In Vivo (2002) (57)
- Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects (2017) (56)
- Clearance and Organ Distribution ofMycobacterium tuberculosis Lipoarabinomannan (LAM) in the Presence and Absence of LAM-Binding Immunoglobulin M (2000) (56)
- Capsule Growth in Cryptococcus neoformans Is Coordinated with Cell Cycle Progression (2014) (56)
- Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers (2020) (56)
- Antibody Binding Alters the Characteristics and Contents of Extracellular Vesicles Released by Histoplasma capsulatum (2016) (55)
- EDTA Inhibits Biofilm Formation, Extracellular Vesicular Secretion, and Shedding of the Capsular Polysaccharide Glucuronoxylomannan by Cryptococcus neoformans (2012) (55)
- Melanization of Cryptococcus neoformans in Murine Infection (1998) (55)
- Pre-clinical evaluation and efficacy studies of a melanin-binding IgM antibody labeled with 188Re against experimental human metastatic melanoma in nude mice (2008) (55)
- Monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan enhance fluconazole efficacy (1995) (55)
- Cryptococcus neoformans differently regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human monocytes (1998) (54)
- Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo (2010) (54)
- What Is a Host? Attributes of Individual Susceptibility (2017) (54)
- A Monoclonal Antibody to Bacillus anthracis Protective Antigen Defines a Neutralizing Epitope in Domain 1 (2006) (54)
- Serum albumin disrupts Cryptococcus neoformans and Bacillus anthracis extracellular vesicles (2012) (54)
- Antibody-Mediated Protection through Cross-Reactivity Introduces a Fungal Heresy into Immunological Dogma (2007) (54)
- Synthetic Consolidants Attacked by Melanin-Producing Fungi: Case Study of the Biodeterioration of Milan (Italy) Cathedral Marble Treated with Acrylics (2006) (54)
- Climate change brings the specter of new infectious diseases. (2020) (54)
- Fcγ Receptor I- and III-Mediated Macrophage Inflammatory Protein 1α Induction in Primary Human and Murine Microglia (2002) (54)
- Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans. (1999) (53)
- Investigation of fungal deterioration of synthetic paint binders using vibrational spectroscopic techniques. (2005) (53)
- Mouse Genetic Background Is a Major Determinant of Isotype-Related Differences for Antibody-Mediated Protective Efficacy against Cryptococcus neoformans12 (2005) (53)
- The ‘Amoeboid Predator-Fungal Animal Virulence’ Hypothesis (2019) (53)
- SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. (2020) (53)
- Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. (2003) (53)
- Melanin, Radiation, and Energy Transduction in Fungi. (2017) (52)
- Extracellular proteins of Cryptococcus neoformans and host antibody response (1997) (52)
- Feasibility of Radioimmunotherapy of Experimental Pneumococcal Infection (2004) (52)
- Human IgG Fc domain engineering enhances antitoxin neutralizing antibody activity. (2014) (52)
- Gamma radiation interacts with melanin to alter its oxidation-reduction potential and results in electric current production. (2011) (51)
- Unlocking the molecular structure of fungal melanin using 13C biosynthetic labeling and solid-state NMR. (2003) (51)
- The volume and hydration of the Cryptococcus neoformans polysaccharide capsule. (2007) (51)
- Phenotypic switching in Cryptococcus neoformans. (2002) (51)
- Structural and functional properties of the Trichosporon asahii glucuronoxylomannan. (2009) (51)
- The weapon potential of a microbe (2004) (51)
- Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework (2020) (51)
- Structural Characterization of Melanin Pigments from Commercial Preparations of the Edible Mushroom Auricularia auricula. (2015) (51)
- Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils (2003) (51)
- A role for vesicular transport of macromolecules across cell walls in fungal pathogenesis (2008) (51)
- Lipid Biosynthetic Genes Affect Candida albicans Extracellular Vesicle Morphology, Cargo, and Immunostimulatory Properties (2015) (51)
- Specialized Science (2014) (51)
- Fungal Diseases in the 21st Century: The Near and Far Horizons (2018) (51)
- Sterol compositions and susceptibilities to amphotericin B of environmental Cryptococcus neoformans isolates are changed by murine passage (1995) (51)
- Impact of Yeast Pigmentation on Heat Capture and Latitudinal Distribution (2018) (51)
- Susceptibility of the Human Pathogenic Fungi Cryptococcus neoformans and Histoplasma capsulatum to γ-Radiation Versus Radioimmunotherapy with α- and β-Emitting Radioisotopes (2004) (50)
- Gender inequalities among authors who contributed equally (2019) (50)
- Cryptotrichosporon anacardii gen. nov., sp. nov., a new trichosporonoid capsulate basidiomycetous yeast from Nigeria that is able to form melanin on niger seed agar. (2007) (50)
- Enhancement of nitric oxide synthesis by macrophages represents an additional mechanism of action for amphotericin B (1997) (50)
- Cryptococcus neoformans var. gattii can exploit Acanthamoeba castellanii for growth. (2004) (50)
- The outcome of Cryptococcus neoformans intracellular pathogenesis in human monocytes (2009) (49)
- Antibody to Cryptococcus neoformans Glucuronoxylomannan Inhibits the Release of Capsular Antigen (2004) (49)
- Involvement of C3a and C5a in Interleukin-8 Secretion by Human Polymorphonuclear Cells in Response to Capsular Material of Cryptococcus neoformans (1998) (49)
- Microbial Immune Suppression Mediated by Direct Engagement of Inhibitory Fc Receptor1 (2006) (49)
- Human microglia mediate anti-Cryptococcus neoformans activity in the presence of specific antibody (1995) (49)
- The Different Binding Patterns of Two Immunoglobulin M Monoclonal Antibodies to Cryptococcus neoformans Serotype A and D Strains Correlate with Serotype Classification and Differences in Functional Assays (1998) (49)
- Capsular Localization of the Cryptococcus neoformans Polysaccharide Component Galactoxylomannan (2008) (49)
- Reforming Science: Structural Reforms (2011) (48)
- Cards of virulence and the global virulome for humans (2006) (48)
- Microbial threat lists: obstacles in the quest for biosecurity? (2010) (48)
- Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status (2011) (48)
- Oscillations in U.S. COVID-19 Incidence and Mortality Data Reflect Diagnostic and Reporting Factors (2020) (48)
- Mechanisms of Cryptococcus neoformans-Mediated Host Damage (2018) (48)
- Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates. (2005) (48)
- Immunogenicity of Bacillus anthracis Protective Antigen Domains and Efficacy of Elicited Antibody Responses Depend on Host Genetic Background (2008) (48)
- Genetic Relationship between Cryptococcus neoformans var. neoformans Strains of Serotypes A and D (1998) (47)
- Microbial melanins for radioprotection and bioremediation (2017) (47)
- Solid-state NMR Reveals the Carbon-based Molecular Architecture of Cryptococcus neoformans Fungal Eumelanins in the Cell Wall* (2015) (47)
- The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. (2000) (47)
- Genetic relatedness of Cryptococcus neoformans clinical isolates grouped with the repetitive DNA probe CNRE-1 (1995) (46)
- Interaction of radiolabeled antibodies with fungal cells and components of the immune system in vitro and during radioimmunotherapy for experimental fungal infection. (2006) (46)
- Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fcgamma receptor function. (1999) (46)
- Antibody Interactions with the Capsule ofCryptococcus neoformans (2000) (46)
- The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19 (2021) (46)
- Fungal killing by mammalian phagocytic cells. (2008) (46)
- The constant region contributes to the antigenic specificity and renal pathogenicity of murine anti-DNA antibodies. (2012) (45)
- Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence (2021) (45)
- Rigorous Science: a How-To Guide (2016) (45)
- Scytalidium dimidiatum Causing Recalcitrant Subcutaneous Lesions Produces Melanin (2004) (45)
- The third age of antimicrobial therapy. (2006) (45)
- SARS-Cov2 variants and convalescent plasma: reality, fallacies, and opportunities. (2021) (45)
- Radioimmunotherapy is more effective than antifungal treatment in experimental cryptococcal infection. (2010) (45)
- Variable Region Identical Immunoglobulins Differing in Isotype Express Different Paratopes* (2012) (45)
- Phenotypic Switching of Cryptococcus neoformans Can Produce Variants That Elicit Increased Intracranial Pressure in a Rat Model of Cryptococcal Meningoencephalitis (2005) (44)
- Correction: Why Has the Number of Scientific Retractions Increased? (2013) (44)
- Cryptococcus neoformans meningitis in the rat. (1996) (44)
- Radial Mass Density, Charge, and Epitope Distribution in the Cryptococcus neoformans Capsule (2006) (44)
- Combined treatment: antifungal drugs with antibodies, cytokines or drugs. (2000) (44)
- Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm‐like microcolony formation (2008) (44)
- Policy: Adaptations of avian flu virus are a cause for concern (2012) (44)
- Antigenic Evidence of Prevalence and Diversity of Mycobacterium tuberculosis Arabinomannan (2004) (44)
- The F-Box Protein Fbp1 Regulates Sexual Reproduction and Virulence in Cryptococcus neoformans (2011) (44)
- Chronological Aging Is Associated with Biophysical and Chemical Changes in the Capsule of Cryptococcus neoformans (2011) (43)
- Macrophage Mitochondrial and Stress Response to Ingestion of Cryptococcus neoformans (2015) (43)
- Susceptibility of melanized and nonmelanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine (1996) (43)
- Innate Signaling Promotes Formation of Regulatory Nitric Oxide–Producing Dendritic Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis (2013) (43)
- Fc- and Complement-Receptor Activation Stimulates Cell Cycle Progression of Macrophage Cells from G1 to S1 (2005) (43)
- Specific Antibody to Cryptococcus neoformans Alters Human Leukocyte Cytokine Synthesis and Promotes T-Cell Proliferation (1998) (43)
- Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. (2003) (43)
- Variable efficacy of passive antibody administration against diverse Cryptococcus neoformans strains (1995) (43)
- Mechanism for the Isotype Dependence of Antibody-Mediated Toxicity in Cryptococcus neoformans-Infected Mice1 (2000) (42)
- Fcγ Receptor Cross-linking Stimulates Cell Proliferation of Macrophages via the ERK Pathway* (2009) (42)
- Identification of Linear Epitopes in Bacillus anthracis Protective Antigen Bound by Neutralizing Antibodies* (2009) (42)
- Intracellular Crystal Formation as a Mechanism of Cytotoxicity in Murine Pulmonary Cryptococcus neoformans Infection (2001) (42)
- Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma (2021) (42)
- Immunoglobulin isotype influences affinity and specificity (2012) (42)
- Faculty Opinions recommendation of Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. (2009) (42)
- Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. (1992) (42)
- Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma (2013) (42)
- Monoclonal antibody therapies against SARS-CoV-2 (2022) (41)
- Cryptococcus neoformans galactoxylomannan is a potent negative immunomodulator, inspiring new approaches in anti-inflammatory immunotherapy. (2011) (41)
- Microbial virulence results from the interaction between host and microorganism. (2003) (41)
- Biogenesis of extracellular vesicles in yeast (2010) (41)
- The Role of Melanin in Fungal Pathogenesis for Animal Hosts. (2019) (41)
- NIH Peer Review Reform—Change We Need, or Lipstick on a Pig? (2009) (41)
- Distribution and impact of yeast thermal tolerance permissive for mammalian infection (2015) (41)
- Isolation and identification of membrane vesicle-associated proteins in Gram-positive bacteria and mycobacteria (2014) (41)
- Circular Dichroism reveals evidence of coupling between immunoglobulin constant and variable region secondary structure. (2010) (40)
- Blastomyces dermatitidis produces melanin in vitro and during infection. (2004) (40)
- Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma (2021) (40)
- The 16S-like, 5.8S and 23S-like rRNAs of the two varieties of Cryptococcus neoformans: sequence, secondary structure, phylogenetic analysis and restriction fragment polymorphisms. (1994) (40)
- Monoclonal Antibodies and Toxins—A Perspective on Function and Isotype (2012) (40)
- Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality (2020) (40)
- Expression of a Mycobacterium tuberculosis Arabinomannan Antigen In Vitro and In Vivo (2001) (40)
- Cryptococcus neoformans: paradigm for the role of antibody immunity against fungi? (1996) (40)
- Radioimmunotherapy of infectious diseases. (2009) (39)
- Inhibition of Human Endothelial Cell Chemokine Production by the Opportunistic Fungal Pathogen Cryptococcus neoformans1 (2000) (39)
- Reactivity patterns and epitope specificities of anti-Cryptococcus neoformans monoclonal antibodies by enzyme-linked immunosorbent assay and dot enzyme assay (1997) (39)
- SEROLOGIC EVIDENCE FOR REGIONAL DIFFERENCES IN PEDIATRIC CRYPTOCOCCAL INFECTION (2007) (39)
- Toward Developing a Universal Treatment for Fungal Disease Using Radioimmunotherapy Targeting Common Fungal Antigens (2012) (39)
- Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans. (1998) (39)
- Phagocytic Activity and Monocyte Chemotactic Protein Expression by Pulmonary Macrophages in Persistent Pulmonary Cryptococcosis (2003) (38)
- Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity (2007) (38)
- A Framework for Improving the Quality of Research in the Biological Sciences (2016) (38)
- Antibodies against Immunodominant Antigens of Mycobacterium tuberculosis in Subjects with Suspected Tuberculosis in the United States Compared by HIV Status (2010) (38)
- Protection of Melanized Cryptococcus neoformans from Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetism (2011) (37)
- Rethinking T cell immunity in oropharyngeal candidiasis (2009) (37)
- The elastic properties of the Cryptococcus neoformans capsule. (2009) (37)
- Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans. (1999) (37)
- Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release. (1999) (37)
- Immunomodulators as an antimicrobial tool (2006) (37)
- Antibody Binding to Cryptococcus neoformans Impairs Budding by Altering Capsular Mechanical Properties (2013) (37)
- Glucuronoxylomannan, galactoxylomannan, and mannoprotein occupy spatially separate and discrete regions in the capsule of Cryptococcus neoformans. (2010) (37)
- Enhancement of HIV type 1 infectivity in vitro by capsular polysaccharide of Cryptococcus neoformans and Haemophilus influenzae. (1994) (37)
- Descriptive Science (2008) (36)
- The Cryptococcus neoformans genome sequencing project (1999) (36)
- The Membrane Phospholipid Binding Protein Annexin A2 Promotes Phagocytosis and Nonlytic Exocytosis of Cryptococcus neoformans and Impacts Survival in Fungal Infection (2016) (36)
- Cryptococcus neoformans: Tripping on Acid in the Phagolysosome (2016) (36)
- A ten-year-old boy with a pulmonary nodule secondary to Cryptococcus neoformans: case report and review of the literature. (2003) (36)
- Exploiting the Redundancy in the Immune System (2003) (36)
- (A)Historical Science (2015) (36)
- Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence (2022) (36)
- Radioimmunotherapy of Experimental Human Metastatic Melanoma with Melanin-Binding Antibodies and in Combination with Dacarbazine (2009) (36)
- Treating Cancer as an Infectious Disease—Viral Antigens as Novel Targets for Treatment and Potential Prevention of Tumors of Viral Etiology (2007) (35)
- Polysaccharide-containing conjugate vaccines for fungal diseases. (2006) (35)
- The effect of L-DOPA on Cryptococcus neoformans growth and gene expression (2011) (35)
- COVID‐19 convalescent plasma: Interim recommendations from the AABB (2021) (35)
- Early Safety Indicators of COVID-19 ConvalescentPlasma in 5,000 Patients (2020) (35)
- A Role for LHC1 in Higher Order Structure and Complement Binding of the Cryptococcus neoformans Capsule (2014) (35)
- Continental Drift and Speciation of the Cryptococcus neoformans and Cryptococcus gattii Species Complexes (2017) (35)
- Serotype distribution of Cryptococcus neoformans in patients in a tertiary care center in India. (2004) (35)
- Coccidioides posadasii produces melanin in vitro and during infection. (2007) (35)
- Thermal Restriction as an Antimicrobial Function of Fever (2016) (34)
- The common Cryptococcus neoformans glucuronoxylomannan M2 motif elicits non-protective antibodies. (2009) (34)
- The Damage–Response Framework as a Tool for the Physician-Scientist to Understand the Pathogenesis of Infectious Diseases (2018) (34)
- Challenges posed by extracellular vesicles from eukaryotic microbes. (2014) (34)
- Answers to naysayers regarding microbial extracellular vesicles. (2019) (34)
- The Ebola Epidemic Crystallizes the Potential of Passive Antibody Therapy for Infectious Diseases (2015) (34)
- Methylxanthine Inhibit Fungal Chitinases and Exhibit Antifungal Activity (2012) (34)
- Antibodies for defense against biological attack (2002) (34)
- Murine IgG1 and IgG3 Isotype Switch Variants Promote Phagocytosis of Cryptococcus neoformans through Different Receptors (2009) (34)
- A call for more science in forensic science (2018) (34)
- COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes (2022) (34)
- Site-specific characterization of the N-linked oligosaccharides of a murine immunoglobulin M by high-performance liquid chromatography/electrospray mass spectrometry. (2003) (33)
- Monoclonal antibody mediated capsular reactions (Quellung) in Cryptococcus neoformans. (1995) (33)
- Graduate Biomedical Science Education Needs a New Philosophy (2017) (33)
- Role of CD45 Signaling Pathway in Galactoxylomannan-Induced T Cell Damage (2010) (33)
- Combination of 5-flucytosine and capsule-binding monoclonal antibody in the treatment of murine Cryptococcus neoformans infections and in vitro. (1996) (33)
- The 5S rRNA and the rRNA intergenic spacer of the two varieties of Cryptococcus neoformans. (1995) (33)
- Increased chitinase expression and fungal‐specific antibodies in the bronchoalveolar lavage fluid of asthmatic children (2012) (33)
- Cryptococcus neoformans Induces Macrophage Inflammatory Protein 1α (MIP-1α) and MIP-1β in Human Microglia: Role of Specific Antibody and Soluble Capsular Polysaccharide (2001) (33)
- Radiolabeled melanin-binding peptides are safe and effective in treatment of human pigmented melanoma in a mouse model of disease. (2006) (33)
- AIDS-related mycoses: the way forward. (2014) (33)
- Molecular Basis for Immunoglobulin M Specificity to Epitopes inCryptococcus neoformans Polysaccharide That Elicit Protective and Nonprotective Antibodies (2001) (33)
- Antibody-Guided Alpha Radiation Effectively Damages Fungal Biofilms (2006) (32)
- Fungal Melanins Differ in Planar Stacking Distances (2012) (32)
- Polysaccharide antigen in brain tissue of AIDS patients with cryptococcal meningitis. (1996) (32)
- Dependence of Macrophage Phagocytic Efficacy on Antibody Concentration (2007) (32)
- Using solid-state NMR to monitor the molecular consequences of Cryptococcus neoformans melanization with different catecholamine precursors. (2012) (32)
- Fungal Polysaccharides: Biological Activity Beyond the Usual Structural Properties (2011) (31)
- A two‐way road: novel roles for fungal extracellular vesicles (2018) (31)
- Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis. (2011) (31)
- Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication (2012) (31)
- Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18. (2009) (31)
- Mechanism of action of antibody to capsular polysaccharide in Cryptococcus neoformans infection. (1998) (31)
- Molecular and Idiotypic Analyses of the Antibody Response to Cryptococcus neoformansGlucuronoxylomannan-Protein Conjugate Vaccine in Autoimmune and Nonautoimmune Mice (1999) (31)
- Melanin (2020) (31)
- Immunogenicity of mycobacterial vesicles in humans: identification of a new tuberculosis antibody biomarker. (2013) (30)
- Susceptibility of the human pathogenic fungi Cryptococcus neoformans and Histoplasma capsulatum to gamma-radiation versus radioimmunotherapy with alpha- and beta-emitting radioisotopes. (2004) (30)
- The Fungal Kingdom: Diverse and Essential Roles in Earth's Ecosystem (2008) (30)
- Antibodies, Immunity, and COVID-19. (2020) (30)
- Analysis of epitope information related to Bacillus anthracis and Clostridium botulinum (2008) (30)
- Binding of the wheat germ lectin to Cryptococcus neoformans chitooligomers affects multiple mechanisms required for fungal pathogenesis. (2013) (30)
- Pulmonary cryptococcosis induces chitinase in the rat (2008) (30)
- The Outcome of the Cryptococcus neoformans–Macrophage Interaction Depends on Phagolysosomal Membrane Integrity (2018) (30)
- Extracellular vesicles and vesicle-free secretome of the protozoa Acanthamoeba castellanii under homeostasis and nutritional stress and their damaging potential to host cells (2018) (30)
- Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro. (2006) (29)
- 32-Phosphorus selectively delivered by listeria to pancreatic cancer demonstrates a strong therapeutic effect (2017) (29)
- Radioimmunotherapy of experimental head and neck squamous cell carcinoma (HNSCC) with E6-specific antibody using a novel HPV-16 positive HNSCC cell line (2011) (29)
- Don't Forget the Fungi When Considering Global Catastrophic Biorisks (2017) (29)
- Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma (2020) (29)
- Phage display library derived peptides that bind to human tumor melanin as potential vehicles for targeted radionuclide therapy of metastatic melanoma. (2007) (29)
- Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study (2021) (29)
- Dual Infections with Pigmented and Albino Strains of Cryptococcus neoformans in Patients with or without Human Immunodeficiency Virus Infection in India (2005) (29)
- Monoclonal antibodies can affect complement deposition on the capsule of the pathogenic fungus Cryptococcus neoformans by both classical pathway activation and steric hindrance (2006) (29)
- Forensic bitemark identification: weak foundations, exaggerated claims (2016) (29)
- Monoclonal antibody-mediated toxicity in Cryptococcus neoformans infection: mechanism and relationship to antibody isotype. (1999) (29)
- Feasibility and prospects for a vaccine to prevent cryptococcosis. (2005) (29)
- Galactoxylomannans from Cryptococcus neoformans Varieties neoformans and grubii Are Structurally and Antigenically Variable (2010) (29)
- Fungal Virulence in a Lepidopteran Model Is an Emergent Property with Deterministic Features (2013) (29)
- Binding of Glucuronoxylomannan to the CD14 Receptor in Human A549 Alveolar Cells Induces Interleukin-8 Production (2006) (29)
- Compton scattering by internal shields based on melanin-containing mushrooms provides protection of gastrointestinal tract from ionizing radiation. (2012) (29)
- Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. (1998) (29)
- Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response (2003) (28)
- Activation of Melanin Synthesis in Alternaria infectoria by Antifungal Drugs (2015) (28)
- What is a pathogen? (2002) (28)
- Analysis and Correction of Inappropriate Image Duplication: the Molecular and Cellular Biology Experience (2018) (28)
- Cryptococcus neoformans infection can elicit protective antibodies in mice. (1994) (28)
- Analysis of Immune Escape Variants from Antibody-Based Therapeutics against COVID-19: A Systematic Review (2021) (28)
- The constant region affects antigen binding of antibodies to DNA by altering secondary structure. (2013) (28)
- SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy (2020) (28)
- Correlation between Serum and Plasma Antibody Titers to Mycobacterial Antigens (2010) (28)
- Is Peer Review Censorship? (2009) (28)
- COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors (2021) (27)
- The weapon potential of human pathogenic fungi. (2006) (27)
- Growth and Pigment Production on d-Tryptophan Medium by Cryptococcus gattii, Cryptococcus neoformans, and Candida albicans (2007) (27)
- The Capsule of Cryptococcus neoformans Modulates Phagosomal pH through Its Acid-Base Properties (2018) (27)
- Chitin-Like Molecules Associate with Cryptococcus neoformans Glucuronoxylomannan To Form a Glycan Complex with Previously Unknown Properties (2012) (27)
- Fcgamma receptor I- and III-mediated macrophage inflammatory protein 1alpha induction in primary human and murine microglia. (2002) (27)
- Cryptococcus neoformans: Latency and Disease (2011) (27)
- A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides* (2016) (27)
- The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis. (2016) (27)
- The methodology for determining the efficacy of antibody-mediated immunity. (2004) (27)
- Factors Contributing to the Success of NIH-Designated Underrepresented Minorities in Academic and Nonacademic Research Positions (2018) (27)
- Melanin as a potential target for radionuclide therapy of metastatic melanoma. (2005) (26)
- Fungal Extracellular Vesicles as Potential Targets for Immune Interventions (2019) (26)
- N-acetylglucosamine affects Cryptococcus neoformans cell-wall composition and melanin architecture. (2017) (26)
- Role of B cells and antibodies in acquired immunity against Mycobacterium tuberculosis. (2015) (26)
- Is the Nobel Prize good for science? (2013) (26)
- Environmental Candida auris and the Global Warming Emergence Hypothesis (2021) (26)
- Global structures of IgG isotypes expressing identical variable regions. (2013) (26)
- COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis (2022) (26)
- Melanin deposition in two Cryptococcus species depends on cell-wall composition and flexibility (2020) (26)
- Generation of biologically active anti‐Cryptococcus neoformans IgG, IgE and IgA isotype switch variant antibodies by acridine orange mutagenesis (1996) (26)
- Human fungal pathogens : a subject collection from Cold Spring Harbor perspectives in medicine (2015) (25)
- Testing Hypotheses on Risk Factors for Scientific Misconduct via Matched-Control Analysis of Papers Containing Problematic Image Duplications (2018) (25)
- Fungal Molecular Pathogenesis: What Can It Do and Why Do We Need It? (2006) (25)
- Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review (2020) (25)
- Septic shock caused by Pseudomonas paucimobilis. (1992) (25)
- Antibodies as delivery vehicles for radioimmunotherapy of infectious diseases (2005) (25)
- Antibodies Produced in Response to Cryptococcus neoformans Pulmonary Infection in Mice Have Characteristics of Nonprotective Antibodies (2004) (25)
- Coping with Multiple Virulence Factors: Which Is Most Important? (2005) (25)
- Disease-enhancing antibodies improve the efficacy of bacterial toxin-neutralizing antibodies. (2013) (25)
- In vitro measurement of phagocytosis and killing of Cryptococcus neoformans by macrophages. (2012) (25)
- Specificity and Diversity of Antibodies to Mycobacterium tuberculosis Arabinomannan (2003) (25)
- A hidden battle in the dirt: Soil amoebae interactions with Paracoccidioides spp (2019) (25)
- Winner takes all. (2012) (24)
- Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility (2016) (24)
- A New Synthesis for Dual Use Research of Concern (2015) (24)
- In Vitro and In Vivo Stability a Cryptococcus neoformans Glucuronoxylomannan Epitope That Elicits Protective Antibodies (1999) (24)
- Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype (2019) (24)
- Serum therapy for Cryptococcal meningitis. (1995) (24)
- An Epistemological Perspective on the Value of Gain-of-Function Experiments Involving Pathogens with Pandemic Potential (2014) (24)
- Passive administration of monoclonal antibodies to Anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis (2008) (24)
- The case for pathogen-specific therapy (2009) (24)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (23)
- Life Science’s Average Publishable Unit (APU) Has Increased over the Past Two Decades (2016) (23)
- Laccase Expression in Murine Pulmonary Cryptococcus neoformans Infection (2005) (23)
- Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19 (2021) (23)
- Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality (2021) (23)
- Neutralizing Monoclonal Antibody to Edema Toxin and Its Effect on Murine Anthrax (2010) (23)
- Galactoxylomannan-Mediated Immunological Paralysis Results from Specific B Cell Depletion in the Context of Widespread Immune System Damage12 (2009) (23)
- The still obscure attributes of cryptococcal glucuronoxylomannan. (2009) (23)
- Demonstration of a common indole-based aromatic core in natural and synthetic eumelanins by solid-state NMR. (2014) (22)
- Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern (2022) (22)
- Unexpected Diversity in the Fine Specificity of Monoclonal Antibodies That Use the Same V Region Gene to Glucuronoxylomannan of Cryptococcus neoformans1 (2004) (22)
- Fungal Melanins and Applications in Healthcare, Bioremediation and Industry (2021) (22)
- Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers (2021) (22)
- Field Science—the Nature and Utility of Scientific Fields (2015) (22)
- Cryptococcus neoformans induces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1beta in human microglia: role of specific antibody and soluble capsular polysaccharide. (2001) (22)
- Relationship of Virulence Factor Expression to Evolved Virulence in Mouse-Passaged Cryptococcus neoformans Lines (2005) (22)
- Sterilization of Mycobacterium tuberculosis Erdman Samples by Antimicrobial Fixation in a Biosafety Level 3 Laboratory (2001) (22)
- Dragotcytosis: Elucidation of the Mechanism for Cryptococcus neoformans Macrophage-to-Macrophage Transfer (2018) (22)
- Cryptococcus neoformans glucuronoxylomannan fractions of different molecular masses are functionally distinct. (2014) (22)
- Exserohilum rostratum fungal meningitis associated with methylprednisolone injections. (2013) (22)
- Characterization of Phenotypic Switching in Cryptococcus neoformans Biofilms (2008) (21)
- Role of Cell Surface Hydrophobicity in the Pathogenesis of Medically-Significant Fungi (2021) (21)
- CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation (2020) (21)
- One Health: Fungal Pathogens of Humans, Animals, and Plants (2019) (21)
- Important Science—It's All about the SPIN (2009) (21)
- Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma (2022) (21)
- Antibodies to Mycobacterium tuberculosis (2017) (21)
- ABO blood group and SARS‐CoV‐2 antibody response in a convalescent donor population (2021) (21)
- Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality. (2021) (21)
- Computational model predicts effective delivery of 188-Re-labeled melanin-binding antibody to metastatic melanoma tumors with wide range of melanin concentrations (2007) (20)
- Radiolabeled Antibodies to Bacillus anthracis Toxins Are Bactericidal and Partially Therapeutic in Experimental Murine Anthrax (2009) (20)
- Microbes and Climate Change: a Research Prospectus for the Future (2022) (20)
- Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1. (2008) (20)
- Mechanistic Science (2009) (20)
- What is infectiveness and how is it involved in infection and immunity? (2015) (20)
- Decreased fluconazole susceptibility of a relapse cryptococcus neoformans isolate after fluconazole treatment (1995) (20)
- Involvement of Glycoreceptors in Galactoxylomannan-Induced T Cell Death1 (2009) (20)
- The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of 188Re‐labeled anti‐E6 C1P5 antibody in cervical cancer in mice (2010) (20)
- Unravelling the interactions of the environmental host Acanthamoeba castellanii with fungi through the recognition by mannose‐binding proteins (2019) (19)
- In fatal COVID-19, the immune response can control the virus but kill the patient (2020) (19)
- Targeting host cells harbouring viruses with radiolabeled antibodies (2007) (19)
- Very low levels of remdesivir resistance in SARS-COV-2 genomes after 18 months of massive usage during the COVID19 pandemic: A GISAID exploratory analysis (2022) (19)
- The Assessment of Convalescent Plasma Efficacy against COVID-19 (2020) (19)
- Dual-Use Research of Concern (DURC) Review at American Society for Microbiology Journals (2015) (19)
- Proteasome inhibitors prevent caspase-1-mediated disease in rodents challenged with anthrax lethal toxin. (2010) (19)
- The Effect of Convalescent Plasma Therapy on COVID-19 Patient Mortality: Systematic Review and Meta-analysis (2021) (19)
- Management of injuries caused by Cryptococcus neoformans--contaminated needles. (1994) (18)
- Variants of a Cryptococcus neoformansStrain Elicit Different Inflammatory Responses in Mice (1999) (18)
- Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources (2022) (18)
- Effect of Amphotericin B on Capsule and Cell Size in Cryptococcus neoformans during Murine Infection (2005) (18)
- The putative flippase Apt1 is required for intracellular membrane architecture and biosynthesis of polysaccharide and lipids in Cryptococcus neoformans. (2017) (18)
- Finite-element model of interaction between fungal polysaccharide and monoclonal antibody in the capsule of Cryptococcus neoformans. (2008) (18)
- Galactoxylomannan Does Not Exhibit Cross-Reactivity in the Platelia Aspergillus Enzyme Immunoassay (2007) (18)
- Divalent Metal Cations Potentiate the Predatory Capacity of Amoeba for Cryptococcus neoformans (2017) (18)
- Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans (2005) (17)
- The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies (2022) (17)
- Enhanced virulence of Histoplasma capsulatum through transfer and surface incorporation of glycans from Cryptococcus neoformans during co-infection (2016) (17)
- Voriconazole Inhibits Melanization in Cryptococcus neoformans (2007) (17)
- The Outcome of Phagocytic Cell Division with Infectious Cargo Depends on Single Phagosome Formation (2008) (17)
- A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan. (2012) (17)
- Combinations of Monoclonal Antibodies to Anthrax Toxin Manifest New Properties in Neutralization Assays (2013) (17)
- Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies. (1994) (17)
- Chemosorption of radiometals of interest to nuclear medicine by synthetic melanins. (2008) (17)
- Presentation of cryptococcal capsular polysaccharide (GXM) on activated antigen‐presenting cells inhibits the T‐suppressor response and enhances delayed‐type hypersensitivity and survival (1997) (17)
- Dysregulation in IL‐12 secretion by neutrophils from HIV‐infected patients (2000) (17)
- Antibody-based vaccine strategies against intracellular pathogens. (2018) (17)
- Novel Antifungal Compounds Discovered in Medicines for Malaria Venture’s Malaria Box (2018) (17)
- Prevalence of Cryptococcus neoformansvar. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) Isolates in New York City (2000) (17)
- ‘Many questions, few answers’ (2008) (17)
- Temporal Kinetics and Quantitative Analysis of Cryptococcus neoformans Nonlytic Exocytosis (2014) (17)
- A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment (2022) (16)
- The intracellular pathogen concept (2019) (16)
- Revolutionary Science (2016) (16)
- A Small Protein Associated with Fungal Energy Metabolism Affects the Virulence of Cryptococcus neoformans in Mammals (2016) (16)
- Structure-function analysis and therapeutic efficacy of antibodies to fungal melanin for melanoma radioimmunotherapy (2018) (16)
- Role of Cln1 during melanization of Cryptococcus neoformans (2015) (16)
- Primary group A streptococcal peritonitis in adults. (1990) (16)
- Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. (2013) (16)
- Phenylalanine hydroxylase (PAH) from the lower eukaryote Leishmania major. (2011) (16)
- Efficacy of voriconazole in experimental Cryptococcus neoformans infection (2006) (16)
- The H5N1 Moratorium Controversy and Debate (2012) (16)
- Cryptococcal Glucoxylomannan Does Not Exhibit Cross-Reactivity in the MVista Histoplasma Antigen Enzyme Immunoassay (2007) (16)
- Crisis in Infectious Diseases: 2 Decades Later. (2017) (16)
- Structural and functional characterization of glycosylation in an immunoglobulin G1 to Cryptococcus neoformans glucuronoxylomannan. (2006) (16)
- Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin‐12Rβ2 subunit on human T cells in vitro through effects mediated by antigen‐presenting cells (2002) (16)
- Radioimmunotherapy Is Effective against High-Inoculum Cryptococcus neoformans Infection in Mice and Does Not Select for Radiation-Resistant Cryptococcal Cells (2009) (16)
- A Dual Role For TGF-β1 in the Control and Persistence of Fungal Pneumonia1 (2005) (16)
- A synthetic glycan array containing Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide fragments allows the mapping of protective epitopes† (2020) (16)
- Anthrax-associated shock. (2008) (16)
- Cryptococcal Traits Mediating Adherence to Biotic and Abiotic Surfaces (2018) (16)
- Immunological options for the treatment of tuberculosis: evaluation of novel therapeutic approaches (2007) (16)
- Normalization of anti-cryptococcal activity and interleukin-12 production after highly active antiretroviral therapy (2000) (15)
- Intranasal Inoculation of Cryptococcus neoformans in Mice Produces Nasal Infection with Rapid Brain Dissemination (2019) (15)
- Amoeba Predation of Cryptococcus neoformans Results in Pleiotropic Changes to Traits Associated with Virulence (2020) (15)
- Glyphosate inhibits melanization and increases susceptibility to infection in insects (2021) (15)
- Comparative Molecular and Immunoregulatory Analysis of Extracellular Vesicles from Candida albicans and Candida auris (2020) (15)
- Treatment of infection with radiolabeled antibodies. (2006) (15)
- Reducing bias: accounting for the order of co-first authors. (2019) (15)
- Melanoma stem cells in experimental melanoma are killed by radioimmunotherapy. (2013) (15)
- Analysis of Cell Cycle and Replication of Mouse Macrophages after In Vivo and In Vitro Cryptococcus neoformans Infection Using Laser Scanning Cytometry (2012) (15)
- Lipids Affect the Cryptococcus neoformans-Macrophage Interaction and Promote Nonlytic Exocytosis (2017) (15)
- Complement-dependent cytotoxicity of an antibody to melanin in radioimmunotherapy of metastatic melanoma. (2013) (15)
- Strain-related differences in antibody-mediated changes in gene expression are associated with differences in capsule and location of binding. (2012) (15)
- On the Emergence of Cryptococcus gattii in the Pacific Northwest: Ballast Tanks, Tsunamis, and Black Swans (2019) (15)
- Involvement of multiple Cryptococcus neoformans strains in a single episode of cryptococcosis and reinfection with novel strains in recurrent infection demonstrated by random amplification of polymorphic DNA and DNA fingerprinting (1995) (15)
- Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial (2022) (14)
- Radiofungicidal Effects of External Gamma Radiation and Antibody-Targeted Beta and Alpha Radiation on Cryptococcus neoformans (2008) (14)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (14)
- Temporal Behavior of Capsule Enlargement by Cryptococcus neoformans (2013) (14)
- Role of the ESCRT Pathway in Laccase Trafficking and Virulence of Cryptococcus neoformans (2020) (14)
- Radioimmunotherapy of Cryptococcus neoformans spares bystander mammalian cells. (2013) (14)
- Biophysical Methods for the Study of Microbial Surfaces (2011) (14)
- Galectin-3 Inhibits Paracoccidioides brasiliensis Growth and Impacts Paracoccidioidomycosis through Multiple Mechanisms (2019) (14)
- Fungal immunity and pathogenesis in mammals versus the invertebrate model organism Galleria mellonella. (2021) (14)
- Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein (2013) (14)
- Characterization of a flocculation‐like phenotype in Cryptococcus neoformans and its effects on pathogenesis (2006) (14)
- On the Need for a National Board To Assess Dual Use Research of Concern (2014) (13)
- Host membrane glycosphingolipids and lipid microdomains facilitate Histoplasma capsulatum internalisation by macrophages (2018) (13)
- Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1 (2022) (13)
- The potential of antibody-mediated immunity in the defence against biological weapons (2005) (13)
- Solid-state NMR spectroscopy identifies three classes of lipids in Cryptococcus neoformans melanized cell walls and whole fungal cells (2020) (13)
- In Fungal Intracellular Pathogenesis, Form Determines Fate (2018) (13)
- Host as the Variable: Model Hosts Approach the Immunological Asymptote (2005) (13)
- Equatorial ring-like channels in the Cryptococcus neoformans polysaccharide capsule. (2006) (13)
- Bioterrorism: Lessons Learned Since the Anthrax Mailings (2011) (13)
- Can Science Help Resolve the Controversy on the Origins of the SARS-CoV-2 Pandemic? (2021) (13)
- Targeting the virus with radioimmunotherapy in virus-associated cancers. (2007) (13)
- The Microbial Capsular Polysaccharide Galactoxylomannan Inhibits IL-17A Production in Circulating T Cells from Rheumatoid Arthritis Patients (2013) (13)
- Cell-wall dyes interfere with Cryptococcus neoformans melanin deposition. (2018) (13)
- Macrophages utilize a bet-hedging strategy for antimicrobial activity in phagolysosomal acidification. (2020) (13)
- Human Serum Contains a Protease That Protects against Cytotoxic Activity of Bacillus anthracis Lethal Toxin In Vitro (2008) (13)
- Microglial nodule encephalitis: limited CNS infection despite disseminated systemic cryptococcosis. (1996) (13)
- Antibody-Mediated Catalysis in Infection and Immunity (2017) (13)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (13)
- Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers (2021) (12)
- The melanization road more traveled by: Precursor substrate effects on melanin synthesis in cell-free and fungal cell systems (2018) (12)
- Why do scientists fabricate and falsify data? A matched-control analysis of papers containing problematic image duplications (2017) (12)
- Rethinking Gain-of-Function Experiments in the Context of the COVID-19 Pandemic (2020) (12)
- Serum IgM Glycosylation Associated with Tuberculosis Infection in Mice (2019) (12)
- Revisiting the Immunoglobulin Intramolecular Signaling Hypothesis. (2016) (12)
- Support Science by Publishing in Scientific Society Journals (2017) (12)
- Variation in Cell Surface Hydrophobicity among Cryptococcus neoformans Strains Influences Interactions with Amoebas (2020) (12)
- Mouse models for the study of fungal pneumonia (2012) (12)
- Paramecium species ingest and kill the cells of the human pathogenic fungus Cryptococcus neoformans. (2010) (12)
- Separated at birth (1999) (12)
- Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6 (2010) (12)
- The H5N1 Manuscript Redaction Controversy (2012) (12)
- Conservation of Intracellular Pathogenic Strategy among Distantly Related Cryptococcal Species (2018) (12)
- Radiolabeled Antibodies for Therapy of Infectious Diseases. (2014) (12)
- Redaction of Sensitive Data in the Publication of Dual Use Research of Concern (2013) (12)
- The History of Cryptococcus and Cryptococcosis (2011) (12)
- The state of latency in microbial pathogenesis. (2020) (12)
- The Architecture and Antigenic Composition of the Polysaccharide Capsule (2011) (12)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (12)
- Sensitivity of sandwich enzyme-linked immunosorbent assay for Cryptococcus neoformans polysaccharide antigen is dependent on the isotypes of the capture and detection antibodies (1995) (12)
- Molecular determinants for a cardiovascular collapse in anthrax. (2014) (11)
- Destruction of microbial collections in response to select agent and toxin list regulations. (2010) (11)
- Renaissance of targeting molecules for melanoma. (2006) (11)
- Pharmacokinetics and biodistribution of a monoclonal antibody to Cryptococcus neoformans capsular polysaccharide antigen in a rat model of cryptococcal meningitis: implications for passive immunotherapy. (1997) (11)
- Immunoreactivity of Cryptococcal Antigen Is Not Stable under Prolonged Incubations in Human Serum (2004) (11)
- Unconventional Constituents and Shared Molecular Architecture of the Melanized Cell Wall of C. neoformans and Spore Wall of S. cerevisiae (2020) (11)
- Treatment of Early and Established Cryptococcus neoformans Infection with Radiolabeled Antibodies in Immunocompetent Mice (2011) (11)
- Laccase Affects the Rate of Cryptococcus neoformans Nonlytic Exocytosis from Macrophages (2020) (11)
- Antibody-Mediated Immobilization of Cryptococcus neoformans Promotes Biofilm Formation (2009) (11)
- Infection of Mice with Aerosolized Mycobacterium tuberculosis: Use of a Nose-Only Apparatus for Delivery of Low Doses of Inocula and Design of an Ultrasafe Facility (2002) (11)
- Variable Region Identical IgA and IgE to Cryptococcus neoformans Capsular Polysaccharide Manifest Specificity Differences* (2015) (11)
- The function of conserved amino acids in or near the complementarity determining regions for related antibodies to Cryptococcus neoformans glucuronoxylomannan. (2003) (11)
- Antibody-based therapies as anti-infective agents. (1998) (11)
- A New Approach to Evaluating the Risk–Benefit Equation for Dual-Use and Gain-of-Function Research of Concern (2018) (10)
- Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcgamma receptors (FcgammaR) and complement receptor (CR)3 expression. (2006) (10)
- Benefits and Costs of Animal Virulence for Microbes (2019) (10)
- Cryptococcus neoformans Capsular GXM Conformation and Epitope Presentation: A Molecular Modelling Study (2020) (10)
- Global Catastrophic Threats from the Fungal Kingdom : Fungal Catastrophic Threats. (2019) (10)
- Mixed staphylococcal and cryptococcal epidural abscess in a patient with AIDS. (1990) (10)
- Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe (2020) (10)
- Macrophage Autophagy in Immunity to Cryptococcus (2012) (10)
- Pathogenesis of Cryptococcus neoformans (2007) (10)
- Current state of the hybridoma technology (1990) (10)
- URA5 GENE OF CRYPTOCOCCUS NEOFORMANS VAR. GATTII: EVIDENCE FOR A CLOSE PHYLOGENETIC RELATIONSHIP BETWEEN C. NEOFORMANS VAR. GATTII AND C. NEOFORMANS VAR. NEOFORMANS (1992) (10)
- Faster Cryptococcus Melanization Increases Virulence in Experimental and Human Cryptococcosis (2020) (9)
- Grant funding: Playing the odds. (2016) (9)
- Updating the fungal infection-mammalian selection hypothesis at the end of the Cretaceous Period (2020) (9)
- Comparative Evaluation of Capsular Polysaccharide-Specific IgM and IgG Antibodies and F(ab′)2 and Fab Fragments as Delivery Vehicles for Radioimmunotherapy of Fungal Infection (2007) (9)
- The future of biological warfare (2012) (9)
- Monoclonal antibodies to Mycobacterium tuberculosis CDC 1551 reveal subcellular localization of MPT51. (2007) (9)
- Identification of environmental and genetic factors important for Cryptococcus neoformans titan cell formation using new in vitro inducing conditions (2017) (9)
- The Buoyancy of Cryptococcus neoformans Is Affected by Capsule Size (2018) (9)
- Fungal Extracellular Vesicles Are Involved in Intraspecies Intracellular Communication (2021) (9)
- Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma (2021) (9)
- Making the scientific literature fail-safe. (2018) (9)
- Monoclonal Antibody 13F1 Produces Annular Immunofluorescence Patterns on Cryptococcus neoformansSerotype AD Isolates (1999) (9)
- Cryptococcus neoformans Secretes Small Molecules That Inhibit IL-1β Inflammasome-Dependent Secretion (2019) (9)
- Why We Cheat (2013) (9)
- Antibody-based defense strategies against biological weapons (2005) (9)
- Automated Measurement of Cryptococcal Species Polysaccharide Capsule and Cell Body. (2018) (9)
- Omics Approaches for Understanding Biogenesis, Composition and Functions of Fungal Extracellular Vesicles (2021) (9)
- Melanization in Cryptococcus neoformans Requires Complex Regulation (2020) (8)
- Phagocytosis Inhibits F-Actin-Enriched Membrane Protrusions Stimulated by Fractalkine (CX3CL1) and Colony-Stimulating Factor 1 (2009) (8)
- Host and microbial cells as targets for armed antibodies in the treatment of infectious diseases. (2008) (8)
- Integrin β1 Promotes the Interaction of Murine IgG3 with Effector Cells (2019) (8)
- Antimicrobial Therapy in the Context of the Damage-Response Framework: the Prospect of Optimizing Therapy by Reducing Host Damage (2019) (8)
- Are convalescent plasma stocks collected during former COVID‐19 waves still effective against current SARS‐CoV‐2 variants? (2022) (8)
- Interstrain variation in the deoxynucleotide composition of Cryptococcus neoformans: nucleotide composition of Cryptococcus neoformans. (1998) (8)
- Neutralizing Antibody LY-CoV555 for Outpatient Covid-19. (2020) (8)
- On Immunologists and Microbiologists: Ground Zero in the Battle for Interdisciplinary Knowledge (2010) (8)
- Pigment Production on L-Tryptophan Medium by Cryptococcus gattii and Cryptococcus neoformans (2014) (8)
- In vitro evaluation, biodistribution and scintigraphic imaging in mice of radiolabeled anthrax toxins. (2008) (8)
- Convalescent Plasma Use in the United States was inversely correlated with COVID-19 Mortality: Did Plasma Hesitancy cost lives? (2021) (8)
- Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic. (2020) (8)
- Cryptococcus neoformans-Infected Macrophages Release Proinflammatory Extracellular Vesicles: Insight into Their Components by Multi-omics (2021) (8)
- Functional Improvement of Regulatory T Cells from Rheumatoid Arthritis Subjects Induced by Capsular Polysaccharide Glucuronoxylomannogalactan (2014) (8)
- First Draft Genome Sequence of the Pathogenic Fungus Lomentospora prolificans (Formerly Scedosporium prolificans) (2017) (8)
- Figure errors, sloppy science, and fraud: keeping eyes on your data. (2019) (7)
- The Apocalypse as a Rhetorical Device in the Influenza Virus Gain-of-Function Debate (2014) (7)
- A point mutation in the Ch3 domain of human IgG3 inhibits antibody secretion without affecting antigen specificity. (2005) (7)
- Labeling of proteins with [35S]methionine and/or [35S]cysteine in the absence of cells. (1999) (7)
- Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources (2022) (7)
- COMPARATIVE ANALYSIS OF ANTIBODY RESPONSES FROM COVID-19 CONVALESCENTS RECEIVING VARIOUS VACCINES REVEALS CONSISTENT HIGH NEUTRALIZING ACTIVITY FOR SARS-CoV-2 VARIANT OF CONCERN OMICRON. (2021) (7)
- The mRNA vaccine revolution is the dividend from decades of basic science research. (2021) (7)
- Pyomelanin Synthesis in Alternaria alternata Inhibits DHN-Melanin Synthesis and Decreases Cell Wall Chitin Content and Thickness (2021) (7)
- How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19? (2022) (7)
- A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis. (2018) (7)
- Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection (2021) (7)
- Mammalian-Transmissible H5N1 Virus: Containment Level and Case Fatality Ratio (2012) (7)
- Convergent Evolution in SARS-CoV-2 Spike Creates a Variant Soup from Which New COVID-19 Waves Emerge (2023) (7)
- Recent Advances on Model Hosts (2012) (7)
- The Importance of Virology at a Time of Great Need and Great Jeopardy (2015) (7)
- Cryptococcus neoformans as a Model for Radioimmunotherapy of Infections (2011) (7)
- Antibody-based therapies for infectious diseases : renaissance for an abandoned arsenal? (1997) (7)
- "Anti-virulence" genes--further muddling the lexicon? Response from Arturo Casadevall and Liise-anne Pirofski. (2003) (7)
- Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children (2021) (7)
- Combination of Antiretroviral Drugs and Radioimmunotherapy Specifically Kills Infected Cells from HIV-Infected Individuals (2016) (7)
- Cryptococcus neoformans melanization incorporates multiple catecholamines to produce polytypic melanin (2021) (6)
- Infectious Diseases Society of America and Gain-of-Function Experiments With Pathogens Having Pandemic Potential (2015) (6)
- Using Preprints for Journal Clubs (2018) (6)
- Duke University’s huge misconduct fine is a reminder to reward rigour (2019) (6)
- Vagueness and Costs of the Pause on Gain-of-Function (GOF) Experiments on Pathogens with Pandemic Potential, Including Influenza Virus (2014) (6)
- Spike mutations in SARS-CoV-2 AY sublineages of the Delta variant of concern: implications for the future of the pandemic (2021) (6)
- Short Communication: Simultaneous Expression of k and λ Light Chains in a Murine IgG3 Anti-Cryptococcus neoformans Hybridoma Cell Line (1994) (6)
- Persistent vancomycin-resistant Enterococcus faecium bacteremia (1997) (6)
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. (2006) (6)
- Experimental murine cryptococcal infection results in contamination of bedding with Cryptococcus neoformans. (2003) (6)
- Exploiting the Redundancy in the Immune System: Vaccines Can Mediate Protection by Eliciting ‘Unnatural’ Immunity (2003) (6)
- Role of Antibody-Mediated Immunity in Host Defense against Mycobacterium tuberculosis (2005) (6)
- Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection (2022) (6)
- Biogenesis and Function of Extracellular Vesicles in Gram-Positive Bacteria, Mycobacteria, and Fungi (2020) (6)
- Inositol Metabolism Regulates Capsule Structure and Virulence in the Human Pathogen Cryptococcus neoformans (2021) (6)
- Caspofungin reduces the incidence of fungal contamination in cell culture (2007) (6)
- Fine Specificity and Idiotype Differing in Isotype Demonstrate Differences Variable-Region-Identical Antibodies (2005) (6)
- Acquired Immunity against Fungi (2002) (6)
- The "nuclearization" of biology is a threat to health and security. (2009) (6)
- Microbicidal Power of Alpha Radiation in Sterilizing Germinating Bacillus anthracis Spores (2013) (6)
- Causes for the Persistence of Impact Factor Mania (2014) (6)
- A glycan FRET assay for detection and characterization of catalytic antibodies to the Cryptococcus neoformans capsule (2020) (5)
- To Be or Not Be a (Functional) Antibody Against TB (2016) (5)
- The fossilization of randomized clinical trials (2022) (5)
- Promoting Responsible Scientific Research (2015) (5)
- Zika Virus Focuses the Gain-of-Function Debate (2016) (5)
- In vitro and in vivo stability of a Cryptococcus neoformans [corrected] glucuronoxylomannan epitope that elicits protective antibodies. (1999) (5)
- Diagnosis and Laboratory Techniques (1998) (5)
- Intracellular cryptococci suppress Fc-mediated cyclin D1 elevation (2010) (5)
- Melanin triggers antifungal defences. (2018) (5)
- The enigmatic role of fungal annexins: the case of Cryptococcus neoformans (2019) (5)
- Fungal Infections (In Humans) (2007) (5)
- WHO covid-19 drugs guideline: reconsider using convalescent plasma (2022) (5)
- The Justification for the Academy Track in mBio (2015) (5)
- In Vitro and In Vivo Stability of a Cryptococcus neoformans Glucuronoxylomannan Epitope That Elicits Protective Antibodies (1999) (5)
- Animal Models and Veterinary Aspects of Cryptococcosis (1998) (5)
- What is the latest approach to pulmonary cryptococcosis (2004) (5)
- The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox (2022) (5)
- Physical Defenses and Nonspecific Immunity (1998) (4)
- Is the Pace of Biomedical Innovation Slowing? (2019) (4)
- 10.3 Melanin and Resistance to Ionizing Radiation in Fungi (2011) (4)
- Antibody immunity and Cryptococcus neoformans (1995) (4)
- Melanin triggers antifungal defences (2018) (4)
- Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19. (2023) (4)
- A practical treatment for COVID‐19 and the next pandemic (2022) (4)
- Introduction to the Pathogen (1998) (4)
- Biological Activity of a Mouse-Human Chimeric Immunoglobulin G2 Antibody to Cryptococcus neoformans Polysaccharide (2002) (4)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (4)
- Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2 (2021) (4)
- Beat the heat: correlates, compounds, and mechanisms involved in fungal thermotolerance (2021) (4)
- Glyphosate Inhibits Melanization and Increases Insect Susceptibility to Infection (2020) (4)
- Cryptococcus neoformans var. neoformans(Serotype D) Strains Are More Susceptible to Heat than C. neoformans var. grubii (Serotype A) Strains (2001) (4)
- Antibodies and fungi: an evolving paradigm with opportunities for the development of new antifungal therapies and vaccines. (1997) (4)
- Opsonin-free, real-time imaging of Cryptococcus neoformans capsule during budding (2018) (4)
- Virology under the Microscope—a Call for Rational Discourse (2023) (4)
- Moonshot Science—Risks and Benefits (2016) (4)
- Recent progress in understanding host-fungal interactions. (2000) (4)
- A New Design for the ASM General Meeting (2010) (4)
- The Silver Lining in Gain-of-Function Experiments with Pathogens of Pandemic Potential (2018) (4)
- The Decision to Publish an Avian H7N1 Influenza Virus Gain-of-Function Experiment (2014) (4)
- Listeria monocytogenes virulence factors are secreted in biologically active Extracellular Vesicles (2017) (4)
- Acquired Antibody-Mediated Immunity to Fungi (2006) (4)
- Thioredoxin Reductase 1 Is a Highly Immunogenic Cell Surface Antigen in Paracoccidioides spp., Candida albicans, and Cryptococcus neoformans (2020) (3)
- Pathogen reduction technologies need to evaluate Fc‐mediated antibody functions (2022) (3)
- Specific Immunity and Cytokines (1998) (3)
- Convergent evolution in SARS-CoV-2 Spike creates a variant soup that causes new COVID-19 waves (2022) (3)
- mBio Addresses the Pause in Gain-of-Function (GOF) Experiments Involving Pathogens with Pandemic Potential (PPP) (2014) (3)
- Innate Signalling Promotes Formation of Regulatory Nitric Oxide-Producing Dendritic Cells Limiting T Cell Expansion in Experimental Autoimmune Myocarditis (2013) (3)
- Erratum: Melanization affects susceptibility of Cryptococcus neoformans to heat and cold (FEMS Microbiol. Lett. (1997) 153 (265-272) PII: S0378109797002395) (1997) (3)
- High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern (2022) (3)
- A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses (2023) (3)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (3)
- Serum-Mediated Cleavage of Bacillus anthracis Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase (2018) (3)
- Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy (2020) (3)
- Reply to “Can Limited Scientific Value of Potential Pandemic Pathogen Experiments Justify the Risks?” (2014) (3)
- Outpatient regimens to reduce COVID-19 hospitalizations: a systematic review and meta-analysis of randomized controlled trials (2022) (3)
- Expanding the Pathogenic Potential Concept To Incorporate Fulminancy, Time, and Virulence Factors (2022) (3)
- Disequilibrium in Gender Ratios among Authors who Contributed Equally (2017) (3)
- Melanin protects Cryptococcus neoformans from spaceflight effects (2022) (3)
- Convalescent plasma for COVID-19. TSUNAMI is not the final word (2022) (3)
- Diseased Science: ”It is more important to know what sort of person has a disease than to know what sort of disease a person has.”— attributed to Hippocrates (2014) (3)
- On the relationship between Pathogenic Potential and Infective Inoculum (2022) (3)
- The Presence of Cryptococcal Capsular Polysaccharide Increases the Sensitivity of HIV‐1 Coculture in Children (1993) (3)
- Two phase I studies of PTI-188, a radiolabeled murine antimelanin antibody, in patients with metastatic melanoma (MM). (2011) (3)
- The damage response framework and infection prevention: From concept to bedside (2020) (3)
- Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 (2022) (3)
- Visualizing non-lytic exocytosis of Cryptococcus neoformans from macrophages using digital light microscopy. (2014) (3)
- Dependence , and Prozone-Like Effects in : Mechanism , Dose Cryptococcus neoformans Immunoglobulin M Efficacy Against (2001) (3)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (3)
- Cryptococcus neoformans capsule regrowth experiments reveal dynamics of enlargement and architecture (2021) (3)
- Microbial Science Research in the Post-COVID Environment (2021) (3)
- Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics? (2021) (3)
- Extracellular Vesicles from Different Pneumococcal Serotypes Are Internalized by Macrophages and Induce Host Immune Responses (2021) (3)
- Weaponising microbes for peace. (2023) (3)
- Q&A: What is a pathogen? A question that begs the point (2012) (3)
- Solid-state NMR spectroscopy identifies three classes of lipids in C. neoformans melanized cell walls and whole fungal cells (2020) (2)
- Acknowledgement of Reviewers (1980) (2)
- Our Health, Our Action, Our Planet—a Call to Action for Microbiologists To Engage in Climate Research (2021) (2)
- Eosinophil-Cryptococcus neoformansInteractions In Vivo and In Vitro (1997) (2)
- Tissue Responses and Special Topics in Immunity (1998) (2)
- Disaster Microbiology—a New Field of Study (2022) (2)
- Convalescent plasma in outpatients with COVID-19 (2022) (2)
- Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics (2023) (2)
- Strengthening the “Ph” in the Ph.D.: The Role of Professional Societies in Graduate Training (2019) (2)
- Oscillations in USA COVID-19 Incidence and Mortality Data reflect societal factors (2020) (2)
- Correction for Fang and Casadevall, Competitive Science: Is Competition Ruining Science? (2015) (2)
- Traitement anti-infectieux par anticorps (2001) (2)
- Fungal Diseases of the Lung. Edited by G.A. Sarosi and S. Davies. (1999) (2)
- Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments” (2014) (2)
- Comparative Evaluation of Profiles of Antibodies to Mycobacterial Capsular Polysaccharides in Tuberculosis Patients and Controls Stratified by HIV Status (2012) (2)
- WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? (2023) (2)
- Erratum for Fang and Casadevall, Research Funding: the Case for a Modified Lottery (2016) (2)
- On Immunologists and Microbiologists: Ground Zero in the Battle for Interdisciplinary Knowledge (2010) (2)
- Protection of the Melanized Fungus Cryptococcus Neoformans From Lethal Dose Gamma Irradiation Involves Changes in Melanin's Chemical Structure and Paramagnetic Properties (2011) (2)
- Pathogenicity of Cryptococcus neoformans: an Evolutionary Perspective (2008) (2)
- Antigenic variation in Cryptococcus neoformans: In vitro and in vivo selection (1997) (2)
- Mu switch region deletion is associated with both T cell independent and T cell dependent responses. (1993) (2)
- Letters to the Editor Involvement of MultipleCryptococcus neoformansStrains in a Single Episode of Cryptococcosis and Reinfection with Novel Strains in Recurrent Infection Demonstrated by Random Amplification of Polymorphic DNA and DNA Fingerprinting (1995) (2)
- Platelet-activating Factor Contributes to Bacillus anthracis Lethal Toxin-associated Damage* (2014) (2)
- Vaccines and Antibody Therapies from Cryptococcus neoformans to Melanoma (2011) (2)
- Elegant Science (2018) (2)
- Convalescent plasma to deliver therapeutic antibodies against COVID-19 (2022) (2)
- Yeast cell death pathway requiring AP-3 vesicle trafficking leads to vacuole/lysosome membrane permeabilization (2022) (2)
- Allergen1 regulates polysaccharide structure in Cryptococcus neoformans (2013) (2)
- Do individual and institutional predictors of misconduct vary by country? Results of a matched-control analysis of problematic image duplications (2022) (2)
- Glycan FRET Probes for Screening Catalytic Antibodies Against Cryptococcus Neoformans Capsule (2020) (2)
- Hypothermia is a characteristic of the fungal kingdom (2020) (2)
- Simultaneous expression of kappa and lambda light chains in a murine IgG3 anti-Cryptococcus neoformans hybridoma cell line. (1994) (2)
- Erratum: In vitro and in vivo stability of a Cryptococcus neoformans glucuronoxylomannan epitope that elicits protective antibodies (Infection and Immunity (1999) 67 (3096-3107)) (1999) (2)
- Construction of mouse Human chimeric antibodies to Cryptococcus neoformans polysaccharide which exhibit biological activity (1993) (2)
- Variation in cell surface hydrophobicity among Cryptococcus neoformans strains influences interactions with amoeba (2019) (2)
- Imaging Cryptococcus spp. Capsule by Differential Interference Contrast Microscopy Using Percoll®. (2019) (2)
- Fungal Infections in Humans (2011) (2)
- Gene-dependent yeast cell death pathway requires AP-3 vesicle trafficking leading to vacuole membrane permeabilization (2021) (2)
- Distribution and impact of yeast thermal tolerance permissive for mammalian infection (2015) (1)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- Outpatient Treatment of Confirmed COVID-19 (2023) (1)
- The evolution of human fungal pathogens. (2006) (1)
- COVID-19 Convalescent Plasma and Concomitant Therapies in PassITON (2022) (1)
- Melanization of Candida auris Is Associated with Alteration of Extracellular pH (2022) (1)
- Phylogenetics and Evolution of Virulence in the Kingdom Fungi (2013) (1)
- ASM Launches mBio (2010) (1)
- Humoral immunity and Cryptococcus neoformans. (2002) (1)
- Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection. (2023) (1)
- Study of Microbial Extracellular Vesicles:Separation by Density Gradients, Protection Assays and Labelling for Live Tracking. (2020) (1)
- Vesicle Isolation from Bacillus subtilis Biofilm. (2015) (1)
- Convalescent plasma in oncohematological patients (2022) (1)
- Use of convalescent plasma in the treatment of COVID-19 (2023) (1)
- Biofilms to Antifungal Agents In Vitro Cryptococcus neoformans Susceptibility of (2006) (1)
- Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe (2019) (1)
- Lya Polysaccharide Responsiveness to Cryptococcal Expression , and Altered Antibody Decreased Inducible Nitric Oxide Synthase Associated with Intracellular Parasitism , Pulmonary Infection in the Rat Is Cryptococcus neoformans Persistent (2000) (1)
- Reply to “On the Impact Factor and the ASM Editorial Policy” (2017) (1)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- Higher Proportion of Female Speakers at Scientific The Presence of Female Conveners Correlates with a 2014 (2014) (1)
- Fc-engineered antibodies leverage neutrophils to drive control of Mycobacterium tuberculosis (2022) (1)
- Melanin: Structure, Function, and Biosynthesis in Cryptococcus (2011) (1)
- Reply to Argüelles and Argüelles-Prieto, “Are the Editors Responsible for Our Obsession with the Impact Factor?” (2017) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- Virology under the Microscope—a Call for Rational Discourse (2023) (1)
- Peer Review of Manuscripts Submitted Via the Academy Fellowship Track (2011) (1)
- Response from Casadevall (1998) (1)
- Virology under the Microscope—a Call for Rational Discourse (2023) (1)
- Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2 (2022) (1)
- The mBio American Academy of Microbiology Submission Track in 2017 (2017) (1)
- Falling down the Rabbit Hole: aTRIP Toward Lexiconic Precision in the “Gain-of-Function” Debate (2014) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- Convalescent plasma for COVID‐19 — encouraging signals of efficacy (2021) (1)
- ASM International Fellowship Program Catalyzes Discovery and Collaboration (2009) (1)
- Binding of the von Willebrand Factor A Domain of Capillary Morphogenesis Protein 2 to Anthrax Protective Antigen Vaccine Reduces Immunogenicity in Mice (2020) (1)
- Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses (2022) (1)
- Antibodies to the Cryptococcus neoformans Capsule have Innate Glycosidase Activity (2020) (1)
- AgMESH, a peritrophic matrix-associated protein embedded in Anopheles gambiae melanotic capsules modulates malaria parasite infection (2021) (1)
- Symptom duration and resolution with early outpatient treatment of convalescent plasma for COVID- 19: a randomized trial. (2023) (1)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (1)
- Human and murine Cryptococcus neoformans infection selects for common genomic changes in an environmental isolate (2022) (1)
- Host Autophagy in Antifungal Immunity (2016) (1)
- Bet-hedging antimicrobial strategies in macrophage phagosome acidification drive the dynamics of Cryptococcus neoformans intracellular escape mechanisms (2021) (1)
- Fungi are colder than their surroundings (2020) (1)
- Correction: Pre-Clinical Evaluation of a 213Bi-Labeled 2556 Antibody to HIV-1 gp41 Glycoprotein in HIV-1 Mouse Models as a Reagent for HIV Eradication (2012) (1)
- Reply to “A Brain Drain due to Increased Regulation of Influenza Virus Research Is Highly Speculative” (2014) (1)
- Microbes and Climate Change - Science, People & Impacts (2022) (1)
- Hinge Influences in Murine IgG Binding to Cryptococcus neoformans Capsule (2021) (1)
- On Election to the Fellowship of the American Academy of Microbiology (2022) (1)
- Carbohydrate-Based Antifungal Vaccines (2008) (1)
- Galleria mellonella immune melanization is fungicidal during infection (2022) (1)
- How does temperature trigger biofilm adhesion and growth in Candida albicans and two non‐Candida albicans Candida species? (2021) (1)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (1)
- Absence of pathogenic viruses in COVID‐19 convalescent plasma (2022) (1)
- Erratum: Cryptococcus neoformans var. neoformans (Serotype D) strains are more susceptible to heat than C. neoformans var. grubii (Serotype A) strains (Journal of Clinical Microbiology (2001) 39:9 (3365-3367)) (2001) (1)
- Amoeba and Slime Mold: Hosts of Virulence Evolution (2006) (1)
- Reforming Science: Reforming scientific methodology, culture, and structure is needed so that scientists, and the enterprise of science itself, can meet the challenges of the future (2012) (1)
- Melanization is an important antifungal defense mechanism in Galleria mellonella hosts (2022) (1)
- Finding evidence for treatment decisions in a pandemic. (2022) (1)
- The Role of the Constant Region in Antibody-Antigen Interactions: Redefining the Modular Model of Immunoglobulin Structure (2018) (1)
- Interactions of Extracellular Vesicles from Pathogenic Fungi with Innate Leukocytes. (2021) (1)
- Paracoccidioides HSP90 Can Be Found in the Cell Surface and is a Target for Antibodies with Therapeutic Potential (2020) (1)
- Erratum for Schloss et al., “Support Science by Publishing in Scientific Society Journals” (2017) (1)
- Cryptococcus neoformans releases proteins during intracellular residence that affect the outcome of the fungal–macrophage interaction (2021) (1)
- Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia (2021) (1)
- Dectin-1 pathway activation is important to Cryptococcus neoformans killing (67.10) (2012) (1)
- Reflections after 2 years of COVID‐19 pandemic (2022) (1)
- COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma (2023) (1)
- Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines (2022) (1)
- High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (2022) (1)
- Therapy of Cryptococcosis (1998) (1)
- Antifungal activity of 2,3-diphenyl-2,3-dihydro-1,3-thiaza-4-ones against two human pathogenic fungi (2020) (1)
- Molecular mechanisms of LC3-associated phagocytosis in the macrophage response to Paracoccidioides spp (2020) (1)
- Cytokine response to Cryptococcus neoformans in murine pulmonary infection (1997) (1)
- Discriminating endogenous vaccine‐elicited anti‐Spike antibody responses from exogenous anti‐Spike monoclonal antibodies: The case of Evusheld (2022) (1)
- The 5S Ribosomal-Rna and the Ribosomal-Rna Intergenic Spacer of the 2 Varieties of Cryptococcus-Neoformans (1995) (0)
- Binding of glucuronoxylomannan to CD14 receptor in human A549 alveolar cells induces IL-8 (2006) (0)
- SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern (2023) (0)
- The Decision To Publish Gutierrez-Alvarez et al., “Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice” (2020) (0)
- Author response: Gender inequalities among authors who contributed equally (2018) (0)
- 2022 Acknowledgment of mBio Invited Editors (2022) (0)
- Differences to Fungal Pneumonia SusceptibilityDeterminant of Species-Related An Innate Immune System Cell Is a Major (2005) (0)
- Interdisciplinary Knowledge Ground Zero in the Battle for On Immunologists and Microbiologists (2011) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Vaccines and Immunology (2007) (0)
- Cryptococcus neoformans glucuronoxylomannan M 2 motif elicits on-protective antibodies (2009) (0)
- Faculty Opinions recommendation of Mixed infections and In Vivo evolution in the human fungal pathogen Cryptococcus neoformans. (2010) (0)
- Glyphosate inhibits melanization of Cryptococcus neoformans and affects survival following systemic infection in mice (1999) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Faculty Opinions recommendation of Human IgG2 can form covalent dimers. (2003) (0)
- Reciprocal modulation of ammonia and melanin production has implications for cryptococcal virulence (2023) (0)
- Acknowledgment of Reviewers (2016) (0)
- Funding : the Case for a Modified Lottery (2016) (0)
- When Is Improvement Not? Worsening Scores after Grant Proposal Revision (2023) (0)
- Acknowledgment of Invited Editors (2019) (0)
- Macrophages utilize a bet-hedging strategy for antimicrobial activity in phagolysosomal acidification (2018) (0)
- Immunity to Fungi (2001) (0)
- India Strains from Cryptococcus neoformans Molecular Epidemiology of Clinical (2005) (0)
- 2022 Acknowledgment of mBio Reviewers (2022) (0)
- Galectin-3 impacts Cryptococcus neoformans infection through direct antifungal effects (2017) (0)
- Late Breaker Symposium (2006) (0)
- Biodefense research: a win-win challenge. (2008) (0)
- Reply to Fiscella: The phases of biomedical research should be studied to optimize health outcomes (2015) (0)
- Acknowledgment of Reviewers (2017) (0)
- Cryptococcus neoformans: intracellular or extracellular? (2001) (0)
- Probing the Molecular Architecture and Assembly of Synthetic and Fungal Melanins with Solid-State NMR (2012) (0)
- Radioimmunotherapy of Fungal Infection with 213Bi-Labeled Antibody, invited (2010) (0)
- and Ferric C . Fang Cultural Reforms Reforming Science : Methodological and (2012) (0)
- Faculty Opinions recommendation of Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. (2003) (0)
- Acknowledgment to Reviewers (2005) (0)
- VORICONAZOLE INHIBITS MELANIZATION IN (2007) (0)
- Faculty Opinions recommendation of Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains. (2003) (0)
- Extrapulmonary nonmeningeal coccidioidomycosis (2004) (0)
- Acknowledgment of Reviewers (1988) (0)
- Abstract #2339: Biodistribution of 188-Rhenium-labeled antibody to E6 viral protein in experimental cervical tumors_a potential highly selective tumor-specific treatment for HPV-related cervical cancer (2009) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- S 1 Macrophage Cells from G Stimulates Cell Cycle Progression of Fc-and Complement-Receptor Activation (2005) (0)
- GUEST COMMENTARY Descriptive Science (cid:1) (2008) (0)
- Temporal Behavior of Capsule Enlargement for (2013) (0)
- Crystal structure of the second Ig domain from mouse Polymeric Immunoglobulin receptor [PSI-NYSGRC-006220] (2013) (0)
- Elucidating the Structural Framework of Synthetic and Fungal Melanins by Solid-State NMR (2013) (0)
- FILLING IN THE SPACES IN CARDIOVASCULAR EPIDEMIOLOGY. (2021) (0)
- Crystal structure of the 4th FN3 domain of human Protein Tyrosine phosphatase, receptor type F [PSI-NYSGRC-006240] (2013) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Septic Thrombophlebitis of the Portal Vein (2010) (0)
- Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy. (2023) (0)
- RatioLevel and Case Fatality Mammalian-Transmissible H5N1 Virus: (2013) (0)
- Antibody for a Polysaccharide Antigen Isotype Can Affect the Fine Specificity of an (2002) (0)
- Welcome and Opening Remarks (2006) (0)
- Diseased Science "Itismoreimportanttoknowwhatsortofpersonhasadiseasethantoknow what sort of disease a person has."— attributed to Hippocrates (2014) (0)
- DEVELOPING A MATHEMATICAL MODEL OF PHAGOCYTOSIS: A LEARNING PROCESS (2007) (0)
- Why do scientists falsify data ? (2017) (0)
- Response to Fehr and Ochsenbein: ‘Good’, ‘bad’ and ‘neutral’ antibodies depend on the host–microbe interaction (2004) (0)
- Experimental Pulmonary Cryptococcus neoformans Infection in Rats (1999) (0)
- for Nitric Oxide Infection: A Role Cryptococcus neoformans Antibody Efficacy in Murine Pulmonary (2002) (0)
- Erratum for Nguyen and Casadevall, “Our Health, Our Action, Our Planet—a Call to Action for Microbiologists To Engage in Climate Research” (2022) (0)
- Characterization of the N-linked glycans of a murine monoclonal antibody 12A1 by LC/MS/MS (2002) (0)
- Acknowledgment of Invited Editors (2018) (0)
- The Holobiont/Hologenome Concept Series (2016) (0)
- Joseph E. Smadel Lecture (2006) (0)
- mBio’s First Birthday (2011) (0)
- Faculty Opinions recommendation of Contribution of the mannan backbone of cryptococcal glucuronoxylomannan and a glycolytic enzyme of Staphylococcus aureus to contact-mediated killing of Cryptococcus neoformans. (2007) (0)
- Correction: On the relationship between Pathogenic Potential and Infective Inoculum (2023) (0)
- Biochemical differentiation of Cryptococcus neoformans var.gattii from Cryptococcits neoformans var. neoformans and var. grubii on D-tryptophan D-proline agar (2006) (0)
- A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses (2023) (0)
- New Developments in Fungal Pathogenesis and Vaccines (2007) (0)
- Virology in Peril and the Greater Risk To Science (2022) (0)
- EXPERIMENTAL MODELS OF CRYPTOCOCCAL MENINGOENCEPHALITIS: CONTRIBUTION OF IMMUNE MOLECULES TO THE RESTRICTION OF CRYPTOCOCCAL PROLIFERATION AND PROPAGATION (1995) (0)
- Radiolabeled antibodies for therapy of infectious diseases. (2014) (0)
- 2021 Acknowledgment of mBio Invited Editors (2021) (0)
- Biomedical briefing (2014) (0)
- Duke University’s huge misconduct fine is a reminder to reward rigour (2019) (0)
- Progress in understanding fungal pathogenesis. (2013) (0)
- RECENT HYBRID PLASMA BETTER NEUTRALIZES OMICRON SUBLINEAGES THAN OLD HYPERIMMUNE SERUM. (2022) (0)
- Synthesis and assembly of fungal melanin (2011) (0)
- Generation of biologically active anti Cryptococcus neoformans isotype switch variant MAbs (1996) (0)
- Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients withMetastatic Melanoma (2013) (0)
- Aharona Therapeutic Studies Polysaccharide That Is a Candidate for Human Cryptococcus neoformans Antibody to Characterization of a Murine Monoclonal (1998) (0)
- Chimeric mouse/human Fab antibodies that selectively binds to the surface of Mycobacterium tuberculosis (MPF6P.649) (2015) (0)
- Faculty Opinions recommendation of Survival, replication, and antibody susceptibility of Ehrlichia chaffeensis outside of host cells. (2003) (0)
- Aging-related changes in lymphatic collectors predispose to pathogen dissemination in tissues (INC4P.342) (2015) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- A process for the application of ionizing radiation at a therapy of HIV infection (2006) (0)
- Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS‐CoV‐2 in a US‐like population (2022) (0)
- V Region Gene to Glucuronoxylomannan of of Monoclonal Antibodies That Use the Same Unexpected Diversity in the Fine Specificity (2004) (0)
- Cryptotrichosporonanacardii gen . nov . , sp . nov . , a new trichosporonoid capsulate basidiomycetousyeast from Nigeria that is able to formmelanin on niger seedagar (2006) (0)
- Faculty Opinions recommendation of Structure-function relationships for human antibodies to pneumococcal capsular polysaccharide from transgenic mice with human immunoglobulin Loci. (2002) (0)
- Capsular Mechanical Properties Impairs Budding by Altering neoformans Cryptococcus Antibody Binding to (2012) (0)
- COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample. (2023) (0)
- Immunotherapy for Fungal Infections (2002) (0)
- The constant region affects antigen binding of anti-DNA antibodies by altering secondary structure (P4002) (2013) (0)
- Acknowledgment of Reviewers (2017) (0)
- Thinking Comes Full Circle Intracellular Pathogens : Two-Dimensional Antibody-Mediated Immunity against (2003) (0)
- mBio Welcomes Clinical Research Papers That Advance Our Understanding of Human-Microbe Interactions (2022) (0)
- On microbial virulence, mammals, and climate change (2022) (0)
- Early Treatment, Inflammation and Post-COVID Conditions (2023) (0)
- Q U E S T I O N & A N S W E R Open Access (2012) (0)
- Correction: Cryptococcus neoformans resists to drastic conditions by switching to viable but non-culturable cell phenotype (2019) (0)
- Correction: Macrophage Mitochondrial and Stress Response to Ingestion of Cryptococcus neoformans (2017) (0)
- Effect of humoral immune mechanisms on the pharmacokinetics, organ distribution and tissue localization of an immunologically active fungal polysaccharide antigen (1997) (0)
- Ten Challenges on Cryptococcus and Cryptococcosis (2011) (0)
- Fungal polysaccharides are altered by lyophilization resulting in decreased antibody binding (2022) (0)
- Cultural Reforms Reforming Science: Methodological and (2014) (0)
- Current state of the hybridoma technology. Discussion (1990) (0)
- Last but not yeast—The many forms of Cryptococcus neoformans (2023) (0)
- the Battle for Interdisciplinary Knowledge On Immunologists and Microbiologists : Ground Zero 2010 (2010) (0)
- Passive Immunization for Infectious Diseases: A Historical Perspective (2004) (0)
- s First Birthday. (2011) (0)
- Descriptive and Hypothesis-Driven Research (2009) (0)
- Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined (2023) (0)
- Acknowledgment of Invited Editors (2014) (0)
- Scientific civility and academic performance (2023) (0)
- Acknowledgment of Reviewers (2016) (0)
- Acknowledgement of Invited Editors (2015) (0)
- Viral antigens as novel targets for radioimmunotherapy of viral cancers (2008) (0)
- Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations (2023) (0)
- Efficacy of high fluence ultraviolet light A (UVA) photoactivation of riboflavin in vitro as a therapy for keratitis (2017) (0)
- Lyophilization induces alterations in cryptococcal exopolysaccharide resulting in reduced antibody binding (2022) (0)
- Radioimmunotherapy for Fungal and Viral Infections (2007) (0)
- Diagnostic and Therapeutic Antibodies Edited by Andrew J. T. George and Catherine E. Urch Totowa, NJ: Humana Press, 2000. 477 pp. (2001) (0)
- Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined (2023) (0)
- Minireview Host-pathogen Interactions: Redefining the Basic Concepts of Virulence and Pathogenicity Historical Views of Microbial Pathogenicity and Virulence (0)
- The buoyant cell density of Cryptococcus neoformans is affected by capsule size (2018) (0)
- Ending the (Cell) wall metaphor in microbiology (2022) (0)
- Expert Opinion on Investigational Drugs (1998) (0)
- Acknowledgment of Reviewers (2014) (0)
- ASM Journals Eliminate Impact Factor Information from Journal Websites (2016) (0)
- Acquired Humoral Immunity to Cryptococcus neoformans (2011) (0)
- A recent Guest Commentary from Infection and Immunity provides some insights on descriptive versus hypothesis-driven research (2008) (0)
- Explaining Order among Those Who Share Positions in the Author Byline (2019) (0)
- Reply to Engelthaler and Meyer, “Furthering the Continental Drift Speciation Hypothesis in the Pathogenic Cryptococcus Species Complexes” (2017) (0)
- Cryptococcus neoformans activates the inflammasome and its capsule plays an important role in this process (P1357) (68.9) (2012) (0)
- What is infectiveness and how is it involved in infection and immunity? (2015) (0)
- Identification and characterization of peptides which bind Cryptococcus neoformans melanin (1997) (0)
- Integrin alpha 4 / beta 1 (CD49d/CD29) is a component of the murine IgG3 receptor (2017) (0)
- Methylxanthine Inhibit Fungal Chitinases and Exhibit Antifungal Activity (2011) (0)
- Rethinking the role of COVID-19 convalescent plasma in the critically ill (2022) (0)
- Crystal structure of bovine CTLA-4, PSI-NYSGRC-012704 (2013) (0)
- A Serum Carboxypeptidase Contributes to the Processing of the Bacillus anthracis Protective Antigen (2015) (0)
- Astrocytes Inhibit Cryptococcus Neos Growth by a Nitric Oxide-mediated Mechanism (2003) (0)
- Continental Drift and Speciation of the <named-content content-type='genus-species'>Cryptococcus neoformans</named-content> and <named-content content-type='genus-species'>Cryptococcus gattii</named-content> Species Complexes (2017) (0)
- Fungal Disease in the 21st Century (2012) (0)
- mechanism of action for amphotericin B. macrophages represents an additional Enhancement of nitric oxide synthesis by (2013) (0)
- A6.2 Purified microbial capsular polysaccharide Galactoxylomannan (GalXM) inhibits the effector T lymphocyte arm and potentiates the regulatory counterpart in rheumatoid arthritis (2014) (0)
- Galectin-3 inhibits Paracoccidioides brasi liensis growth and impacts paracoccidioidomycosis through multiple mechanisms (2019) (0)
- Cryptococcus neoformans: Nonvertebrate Hosts and the Emergence of Virulence (2011) (0)
- Virology in Peril and the Greater Risk To Science (2022) (0)
- Exploring Space via Astromycology: A Report on the CIFAR Programs Earth 4D and Fungal Kingdom Inaugural Joint Meeting. (2022) (0)
- Fc‐RECEPTOR CROSSLINKING STIMULATES CELL CYCLE PROGRESSION OF MACROPHAGES VIA THE ERK PATHWAY (2008) (0)
- Natural Melanin Produced in Fungi Protects Cells from High Dose Ionizing Radiation: An EPR Study (2010) (0)
- Using Laser Scanning Cytometry Cryptococcus neoformans Infection Vitro In and In Vivo Mouse Macrophages after Analysis of Cell Cycle and Replication of (2012) (0)
- Crystal structure of a strand swapped CTLA-4 from Duckbill Platypus [PSI-NYSGRC-012711] (2013) (0)
- Acknowledgment of Invited Editors (2014) (0)
- , Cells Limiting T-Cell Expansion in Experimental Autoimmune Myocarditis Producing Dendritic − Innate Signaling Promotes Formation of Regulatory Nitric Oxide (2013) (0)
- Prevention of Human Infection (1998) (0)
- Specialized Science: While specialization in science brings many advantages, it can have serious drawbacks as well (2014) (0)
- A Critical Analysis of the Evidence for the SARS-CoV-2 Origin Hypotheses (2023) (0)
- Crystal Structure of 3E5 IgG3 FAB from mus musculus (2013) (0)
- Antibody Therapy for Medical Mycoses (2008) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- This information is current as that Elicit Protective Antibodies Capsular Glucuronoxylomannan neoformans Cryptococcus Epitopes of Serotype D Monoclonal Antibodies Reveal Additional (1998) (0)
- Oversight of Pathogen Research Must Be Carefully Calibrated and Clearly Defined (2023) (0)
- Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19 (2022) (0)
- Cryptococcus neoformans against for Antibody-Mediated Protective Efficacy Determinant of Isotype-Related Differences Mouse Genetic Background Is a Major (2005) (0)
- Reply to “Improving Microbiology Research: the Problems Are Less Statistical and More Biological” (2016) (0)
- The Immunoglobulin Heavy Chain Constant Region Affects Kinetic and Thermodynamic Parameters of Antibody Variable (2007) (0)
- Author index (1996) (0)
- Author response: Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality (2021) (0)
- Competitive Science: Is Competition Ruining Science?: Science has always been competitive, and despite recognition of the benefits of cooperation, the struggle for funding and jobs has made science more competitive than ever (2015) (0)
- Acknowledgment of Invited Editors (2020) (0)
- Antibody-Mediated Immunity to Fungi in the Lungs (2005) (0)
- Thinking about Social Media, Scientific Information, and Public Communication (2022) (0)
- Cryptococcus neoformans Virulence Assay Using a Galleria mellonella Larvae Model System. (2022) (0)
- Structure of CNAG_02591 from Cryptococcus neoformans (2014) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Diagnostic and Therapeutic Antibodies:Diagnostic and Therapeutic Antibodies (2001) (0)
- The Journal of Clinical Investigation in the time of COVID-19. (2021) (0)
- Crystal structure of an internal FN3 domain from human Contactin-5 [PSI-NYSGRC-005804] (2013) (0)
- Bactericidal ultraviolet light A (UVA) photoactivation of riboflavin potentiated by low levels of hydrogen peroxide in vitro: a potential novel therapy for methicillin sensitive and multidrug resistant-methicillin resistant Staphylococcus aureus keratitis (2017) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Differentiation of Naturally Produced Extracellular Membrane Vesicles from Lipid Aggregation by Glucuronoxylomannan Immunogold Transmission Electron Microscopy in Bacillus subtilis. (2015) (0)
- A Global Forum for Clinical Microbiologists and Immunologists (2012) (0)
- Thank you to The LANCET Regional Health - Americas’s clinical and statistical peer reviewers in 2021 (2022) (0)
- Faculty Opinions recommendation of Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. (2001) (0)
- Melaninization Reduces Cryptococcus neoformans Susceptibility to Mechanical Stress (2022) (0)
- Was Coccidioides a Pre-Columbian Hitchhiker to Southcentral Washington? (2023) (0)
- DebateH5N1 Moratorium Controversy and (2013) (0)
- Chapter 42 Sex differences in COVID-19 susceptibility – Reductionistic and holistic perspectives (2023) (0)
- Lyophilization induces physicochemical alterations in cryptococcal exopolysaccharide (2022) (0)
- The ASM Journals Committee Values the Contributions of Black Microbiologists (2020) (0)
- Polysaccharides of Fungal Origin (2021) (0)
- 2021 Acknowledgment of mBio Reviewers (2021) (0)
- On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy (2022) (0)
- The hypothermic nature of fungi. (2023) (0)
- Structural motifs suggestive of hydrolytic activity are common among three-dimensional antibody structures (IRM9P.722) (2014) (0)
- Defining B. Anthracis Protective Antigen Antigenic Domains (2008) (0)
- The Role of B Cells in the Immune Response to Mycobacterium tuberculosis. (43.3) (2012) (0)
- Chemokine production by cytokine-treated human endothelial cells and astrocytes is altered by Cryptococcus neoformans and restored by interferon-γ (1998) (0)
- GUEST Antibody-Mediated Protection through Cross-Reactivity Introduces a Fungal Heresy into Immunological Dogma (cid:1) (2007) (0)
- Reply to “Likelihood of False-Positive Results in High-Impact Journals Publishing Groundbreaking Research” (2012) (0)
- Acknowledgment of Invited Editors (2017) (0)
- Faculty Opinions recommendation of Experimental paracoccidioides brasiliensis infection in mice: influence of the hormonal status of the host on tissue responses. (2002) (0)
- ANTI-TB MONOCLONAL ANTIBODIES FOR THE DETECTION OF M. TUBERCULOSIS. 1019 (1996) (0)
- Chance is an important element in phagolysosomal acidification that favors the macrophage (2018) (0)
- Thecaseforpathogen-specific therapy (2009) (0)
- Faculty Opinions recommendation of A novel glyco-conjugate vaccine against fungal pathogens. (2005) (0)
- Virology in Peril and the Greater Risk To Science (2022) (0)
- Pre-clinical development of a 188Re-labeled melanin-binding antibody for phase I clinical trial in patients with metastatic melanoma (2008) (0)
- Debate the H5n1 Moratorium Controversy And (2012) (0)
- How does radioimmunotherapy of infection work? Radiobiological mechanisms of action (2006) (0)
- Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release 1: Scanning electron microscopy of C. neoformans (2008) (0)
- Antibody-Based Defense Strategies against Biological Weapons An immune-based approach against infectious diseases developed near the end of the 19 th century brings renewed opportunities at the start of the 21 st (2004) (0)
- Reply to “Funding by Lottery: Political Problems and Research Opportunities” (2016) (0)
- Cuticular profiling of insecticide resistant Aedes aegypti (2023) (0)
- Nucleic Acids Research (0)
- Abstract 5344: The contribution of unlabeled antibodies to intracellular antigens to efficacy of radioimmunotherapy in experimental metastatic melanoma and cervical cancer (2010) (0)
- Chaotic signatures in host-microbe interactions (2022) (0)
- Bactericidal activity of photoactivated riboflavin, ultraviolet light A, and hydrogen peroxide against stationary phase methicillin-resistant Staphylococcus aureus (MRSA) for potential use in bacterial keratitis (2017) (0)
- The Role of B Cells in the Immune Response to Mycobacterium tuberculosis. (2012) (0)
This paper list is powered by the following services:
Other Resources About Arturo Casadevall
What Schools Are Affiliated With Arturo Casadevall?
Arturo Casadevall is affiliated with the following schools:
- Yeshiva University
- Georgia State University
- Long Island University
- Queens College, City University of New York
- New York University
- University of Kent
- Albert Einstein College of Medicine
- Federal University of Rio de Janeiro
- Johns Hopkins University
- University of Nevada, Reno
- University of Washington
- University of Pittsburgh
- University of Miami
